Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood
Identifieur interne : 000516 ( Pmc/Corpus ); précédent : 000515; suivant : 000517Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood
Auteurs : Miriam Erlacher ; Brigitte StrahmSource :
- Frontiers in Pediatrics [ 2296-2360 ] ; 2015.
Abstract
Peripheral blood cytopenia in children can be due to a variety of acquired or inherited diseases. Genetic disorders affecting a single hematopoietic lineage are frequently characterized by typical bone marrow findings, such as lack of progenitors or maturation arrest in congenital neutropenia or a lack of megakaryocytes in congenital amegakaryocytic thrombocytopenia, whereas antibody-mediated diseases such as autoimmune neutropenia are associated with a rather unremarkable bone marrow morphology. By contrast, pancytopenia is frequently associated with a hypocellular bone marrow, and the differential diagnosis includes acquired aplastic anemia, myelodysplastic syndrome, inherited bone marrow failure syndromes such as Fanconi anemia and dyskeratosis congenita, and a variety of immunological disorders including hemophagocytic lymphohistiocytosis. Thorough bone marrow analysis is of special importance for the diagnostic work-up of most patients. Cellularity, cellular composition, and dysplastic signs are the cornerstones of the differential diagnosis. Pancytopenia in the presence of a normo- or hypercellular marrow with dysplastic changes may indicate myelodysplastic syndrome. More challenging for the hematologist is the evaluation of the hypocellular bone marrow. Although aplastic anemia and hypocellular refractory cytopenia of childhood (RCC) can reliably be differentiated on a morphological level, the overlapping pathophysiology remains a significant challenge for the choice of the therapeutic strategy. Furthermore, inherited bone marrow failure syndromes are usually associated with the morphological picture of RCC, and the recognition of these entities is essential as they often present a multisystem disease requiring different diagnostic and therapeutic approaches. This paper gives an overview over the different disease entities presenting with (pan)cytopenia, their pathophysiology, characteristic bone marrow findings, and therapeutic approaches.
Url:
DOI: 10.3389/fped.2015.00064
PubMed: 26217651
PubMed Central: 4500095
Links to Exploration step
PMC:4500095Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood</title><author><name sortKey="Erlacher, Miriam" sort="Erlacher, Miriam" uniqKey="Erlacher M" first="Miriam" last="Erlacher">Miriam Erlacher</name><affiliation><nlm:aff id="aff1"><institution>Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></nlm:aff></affiliation><affiliation><nlm:aff id="aff2"><institution>Freiburg Institute for Advanced Studies, University of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></nlm:aff></affiliation></author><author><name sortKey="Strahm, Brigitte" sort="Strahm, Brigitte" uniqKey="Strahm B" first="Brigitte" last="Strahm">Brigitte Strahm</name><affiliation><nlm:aff id="aff1"><institution>Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26217651</idno><idno type="pmc">4500095</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500095</idno><idno type="RBID">PMC:4500095</idno><idno type="doi">10.3389/fped.2015.00064</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000516</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000516</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood</title><author><name sortKey="Erlacher, Miriam" sort="Erlacher, Miriam" uniqKey="Erlacher M" first="Miriam" last="Erlacher">Miriam Erlacher</name><affiliation><nlm:aff id="aff1"><institution>Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></nlm:aff></affiliation><affiliation><nlm:aff id="aff2"><institution>Freiburg Institute for Advanced Studies, University of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></nlm:aff></affiliation></author><author><name sortKey="Strahm, Brigitte" sort="Strahm, Brigitte" uniqKey="Strahm B" first="Brigitte" last="Strahm">Brigitte Strahm</name><affiliation><nlm:aff id="aff1"><institution>Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></nlm:aff></affiliation></author></analytic><series><title level="j">Frontiers in Pediatrics</title><idno type="eISSN">2296-2360</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Peripheral blood cytopenia in children can be due to a variety of acquired or inherited diseases. Genetic disorders affecting a single hematopoietic lineage are frequently characterized by typical bone marrow findings, such as lack of progenitors or maturation arrest in congenital neutropenia or a lack of megakaryocytes in congenital amegakaryocytic thrombocytopenia, whereas antibody-mediated diseases such as autoimmune neutropenia are associated with a rather unremarkable bone marrow morphology. By contrast, pancytopenia is frequently associated with a hypocellular bone marrow, and the differential diagnosis includes acquired aplastic anemia, myelodysplastic syndrome, inherited bone marrow failure syndromes such as Fanconi anemia and dyskeratosis congenita, and a variety of immunological disorders including hemophagocytic lymphohistiocytosis. Thorough bone marrow analysis is of special importance for the diagnostic work-up of most patients. Cellularity, cellular composition, and dysplastic signs are the cornerstones of the differential diagnosis. Pancytopenia in the presence of a normo- or hypercellular marrow with dysplastic changes may indicate myelodysplastic syndrome. More challenging for the hematologist is the evaluation of the hypocellular bone marrow. Although aplastic anemia and hypocellular refractory cytopenia of childhood (RCC) can reliably be differentiated on a morphological level, the overlapping pathophysiology remains a significant challenge for the choice of the therapeutic strategy. Furthermore, inherited bone marrow failure syndromes are usually associated with the morphological picture of RCC, and the recognition of these entities is essential as they often present a multisystem disease requiring different diagnostic and therapeutic approaches. This paper gives an overview over the different disease entities presenting with (pan)cytopenia, their pathophysiology, characteristic bone marrow findings, and therapeutic approaches.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Doulatov, S" uniqKey="Doulatov S">S Doulatov</name></author><author><name sortKey="Notta, F" uniqKey="Notta F">F Notta</name></author><author><name sortKey="Laurenti, E" uniqKey="Laurenti E">E Laurenti</name></author><author><name sortKey="Dick, Je" uniqKey="Dick J">JE Dick</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Laurenti, E" uniqKey="Laurenti E">E Laurenti</name></author><author><name sortKey="Dick, Je" uniqKey="Dick J">JE Dick</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sanjuan Pla, A" uniqKey="Sanjuan Pla A">A Sanjuan-Pla</name></author><author><name sortKey="Macaulay, Ic" uniqKey="Macaulay I">IC Macaulay</name></author><author><name sortKey="Jensen, Ct" uniqKey="Jensen C">CT Jensen</name></author><author><name sortKey="Woll, Ps" uniqKey="Woll P">PS Woll</name></author><author><name sortKey="Luis, Tc" uniqKey="Luis T">TC Luis</name></author><author><name sortKey="Mead, A" uniqKey="Mead A">A Mead</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Janus, J" uniqKey="Janus J">J Janus</name></author><author><name sortKey="Moerschel, Sk" uniqKey="Moerschel S">SK Moerschel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Balduini, Cl" uniqKey="Balduini C">CL Balduini</name></author><author><name sortKey="Savoia, A" uniqKey="Savoia A">A Savoia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Blajchman, Ma" uniqKey="Blajchman M">MA Blajchman</name></author><author><name sortKey="Senyi, Af" uniqKey="Senyi A">AF Senyi</name></author><author><name sortKey="Hirsh, J" uniqKey="Hirsh J">J Hirsh</name></author><author><name sortKey="Genton, E" uniqKey="Genton E">E Genton</name></author><author><name sortKey="George, Jn" uniqKey="George J">JN George</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Skokowa, J" uniqKey="Skokowa J">J Skokowa</name></author><author><name sortKey="Germeshausen, M" uniqKey="Germeshausen M">M Germeshausen</name></author><author><name sortKey="Zeidler, C" uniqKey="Zeidler C">C Zeidler</name></author><author><name sortKey="Welte, K" uniqKey="Welte K">K Welte</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Al Herz, W" uniqKey="Al Herz W">W Al-Herz</name></author><author><name sortKey="Bousfiha, A" uniqKey="Bousfiha A">A Bousfiha</name></author><author><name sortKey="Casanova, Jl" uniqKey="Casanova J">JL Casanova</name></author><author><name sortKey="Chatila, T" uniqKey="Chatila T">T Chatila</name></author><author><name sortKey="Conley, Me" uniqKey="Conley M">ME Conley</name></author><author><name sortKey="Cunningham Rundles, C" uniqKey="Cunningham Rundles C">C Cunningham-Rundles</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mostoufi Zadeh, M" uniqKey="Mostoufi Zadeh M">M Mostoufi-Zadeh</name></author><author><name sortKey="Weiss, Lm" uniqKey="Weiss L">LM Weiss</name></author><author><name sortKey="Driscoll, Sg" uniqKey="Driscoll S">SG Driscoll</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mehta, V" uniqKey="Mehta V">V Mehta</name></author><author><name sortKey="Balachandran, C" uniqKey="Balachandran C">C Balachandran</name></author><author><name sortKey="Lonikar, V" uniqKey="Lonikar V">V Lonikar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Villa, A" uniqKey="Villa A">A Villa</name></author><author><name sortKey="Notarangelo, Ld" uniqKey="Notarangelo L">LD Notarangelo</name></author><author><name sortKey="Roifman, Cm" uniqKey="Roifman C">CM Roifman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Valent, P" uniqKey="Valent P">P Valent</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rinaldi, M" uniqKey="Rinaldi M">M Rinaldi</name></author><author><name sortKey="Perricone, C" uniqKey="Perricone C">C Perricone</name></author><author><name sortKey="Ortega Hernandez, Od" uniqKey="Ortega Hernandez O">OD Ortega-Hernandez</name></author><author><name sortKey="Perricone, R" uniqKey="Perricone R">R Perricone</name></author><author><name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mckenzie, Se" uniqKey="Mckenzie S">SE McKenzie</name></author><author><name sortKey="Sachais, Bs" uniqKey="Sachais B">BS Sachais</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Youinou, P" uniqKey="Youinou P">P Youinou</name></author><author><name sortKey="Jamin, C" uniqKey="Jamin C">C Jamin</name></author><author><name sortKey="Le Pottier, L" uniqKey="Le Pottier L">L Le Pottier</name></author><author><name sortKey="Renaudineau, Y" uniqKey="Renaudineau Y">Y Renaudineau</name></author><author><name sortKey="Hillion, S" uniqKey="Hillion S">S Hillion</name></author><author><name sortKey="Pers, Jo" uniqKey="Pers J">JO Pers</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bass, Gf" uniqKey="Bass G">GF Bass</name></author><author><name sortKey="Tuscano, Et" uniqKey="Tuscano E">ET Tuscano</name></author><author><name sortKey="Tuscano, Jm" uniqKey="Tuscano J">JM Tuscano</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Haddad, E" uniqKey="Haddad E">E Haddad</name></author><author><name sortKey="Cramer, E" uniqKey="Cramer E">E Cramer</name></author><author><name sortKey="Riviere, C" uniqKey="Riviere C">C Rivière</name></author><author><name sortKey="Rameau, P" uniqKey="Rameau P">P Rameau</name></author><author><name sortKey="Louache, F" uniqKey="Louache F">F Louache</name></author><author><name sortKey="Guichard, J" uniqKey="Guichard J">J Guichard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sponzilli, I" uniqKey="Sponzilli I">I Sponzilli</name></author><author><name sortKey="Notarangelo, Ld" uniqKey="Notarangelo L">LD Notarangelo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dale, Dc" uniqKey="Dale D">DC Dale</name></author><author><name sortKey="Cottle, Te" uniqKey="Cottle T">TE Cottle</name></author><author><name sortKey="Fier, Cj" uniqKey="Fier C">CJ Fier</name></author><author><name sortKey="Bolyard, Aa" uniqKey="Bolyard A">AA Bolyard</name></author><author><name sortKey="Bonilla, Ma" uniqKey="Bonilla M">MA Bonilla</name></author><author><name sortKey="Boxer, La" uniqKey="Boxer L">LA Boxer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zeidler, C" uniqKey="Zeidler C">C Zeidler</name></author><author><name sortKey="Germeshausen, M" uniqKey="Germeshausen M">M Germeshausen</name></author><author><name sortKey="Klein, C" uniqKey="Klein C">C Klein</name></author><author><name sortKey="Welte, K" uniqKey="Welte K">K Welte</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Klein, C" uniqKey="Klein C">C Klein</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Makaryan, V" uniqKey="Makaryan V">V Makaryan</name></author><author><name sortKey="Zeidler, C" uniqKey="Zeidler C">C Zeidler</name></author><author><name sortKey="Bolyard, Aa" uniqKey="Bolyard A">AA Bolyard</name></author><author><name sortKey="Skokowa, J" uniqKey="Skokowa J">J Skokowa</name></author><author><name sortKey="Rodger, E" uniqKey="Rodger E">E Rodger</name></author><author><name sortKey="Kelley, Ml" uniqKey="Kelley M">ML Kelley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kishnani, Ps" uniqKey="Kishnani P">PS Kishnani</name></author><author><name sortKey="Austin, Sl" uniqKey="Austin S">SL Austin</name></author><author><name sortKey="Abdenur, Je" uniqKey="Abdenur J">JE Abdenur</name></author><author><name sortKey="Arn, P" uniqKey="Arn P">P Arn</name></author><author><name sortKey="Bali, Ds" uniqKey="Bali D">DS Bali</name></author><author><name sortKey="Boney, A" uniqKey="Boney A">A Boney</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wong, Cc" uniqKey="Wong C">CC Wong</name></author><author><name sortKey="Traynor, D" uniqKey="Traynor D">D Traynor</name></author><author><name sortKey="Basse, N" uniqKey="Basse N">N Basse</name></author><author><name sortKey="Kay, Rr" uniqKey="Kay R">RR Kay</name></author><author><name sortKey="Warren, Aj" uniqKey="Warren A">AJ Warren</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shalev, H" uniqKey="Shalev H">H Shalev</name></author><author><name sortKey="Kapelushnik, J" uniqKey="Kapelushnik J">J Kapelushnik</name></author><author><name sortKey="Moser, A" uniqKey="Moser A">A Moser</name></author><author><name sortKey="Dgany, O" uniqKey="Dgany O">O Dgany</name></author><author><name sortKey="Krasnov, T" uniqKey="Krasnov T">T Krasnov</name></author><author><name sortKey="Tamary, H" uniqKey="Tamary H">H Tamary</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ball, S" uniqKey="Ball S">S Ball</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rivella, S" uniqKey="Rivella S">S Rivella</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sawada, K" uniqKey="Sawada K">K Sawada</name></author><author><name sortKey="Hirokawa, M" uniqKey="Hirokawa M">M Hirokawa</name></author><author><name sortKey="Fujishima, N" uniqKey="Fujishima N">N Fujishima</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gangat, N" uniqKey="Gangat N">N Gangat</name></author><author><name sortKey="Wolanskyj, Ap" uniqKey="Wolanskyj A">AP Wolanskyj</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sankaran, Vg" uniqKey="Sankaran V">VG Sankaran</name></author><author><name sortKey="Weiss, Mj" uniqKey="Weiss M">MJ Weiss</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Geddis, Ae" uniqKey="Geddis A">AE Geddis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Albers, Ca" uniqKey="Albers C">CA Albers</name></author><author><name sortKey="Newbury Ecob, R" uniqKey="Newbury Ecob R">R Newbury-Ecob</name></author><author><name sortKey="Ouwehand, Wh" uniqKey="Ouwehand W">WH Ouwehand</name></author><author><name sortKey="Ghevaert, C" uniqKey="Ghevaert C">C Ghevaert</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Owen, C" uniqKey="Owen C">C Owen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Diz Kucukkaya, R" uniqKey="Diz Kucukkaya R">R Diz-Kucukkaya</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Martino, R" uniqKey="Martino R">R Martino</name></author><author><name sortKey="Mu Iz Diaz, E" uniqKey="Mu Iz Diaz E">E Muñiz-Díaz</name></author><author><name sortKey="Arilla, M" uniqKey="Arilla M">M Arilla</name></author><author><name sortKey="Iba Ez, M" uniqKey="Iba Ez M">M Ibáñez</name></author><author><name sortKey="Altes, A" uniqKey="Altes A">A Altés</name></author><author><name sortKey="Guanyabens, C" uniqKey="Guanyabens C">C Guanyabens</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Seidel, Mg" uniqKey="Seidel M">MG Seidel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Seif, Ae" uniqKey="Seif A">AE Seif</name></author><author><name sortKey="Manno, Cs" uniqKey="Manno C">CS Manno</name></author><author><name sortKey="Sheen, C" uniqKey="Sheen C">C Sheen</name></author><author><name sortKey="Grupp, Sa" uniqKey="Grupp S">SA Grupp</name></author><author><name sortKey="Teachey, Dt" uniqKey="Teachey D">DT Teachey</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Teachey, Dt" uniqKey="Teachey D">DT Teachey</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fleisher, Ta" uniqKey="Fleisher T">TA Fleisher</name></author><author><name sortKey="Oliveira, Jb" uniqKey="Oliveira J">JB Oliveira</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Oliveira, Jb" uniqKey="Oliveira J">JB Oliveira</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Verbsky, Jw" uniqKey="Verbsky J">JW Verbsky</name></author><author><name sortKey="Chatila, Ta" uniqKey="Chatila T">TA Chatila</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moraes Vasconcelos, D" uniqKey="Moraes Vasconcelos D">D Moraes-Vasconcelos</name></author><author><name sortKey="Costa Carvalho, Bt" uniqKey="Costa Carvalho B">BT Costa-Carvalho</name></author><author><name sortKey="Torgerson, Tr" uniqKey="Torgerson T">TR Torgerson</name></author><author><name sortKey="Ochs, Hd" uniqKey="Ochs H">HD Ochs</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Janka, Ge" uniqKey="Janka G">GE Janka</name></author><author><name sortKey="Lehmberg, K" uniqKey="Lehmberg K">K Lehmberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lehmberg, K" uniqKey="Lehmberg K">K Lehmberg</name></author><author><name sortKey="Ehl, S" uniqKey="Ehl S">S Ehl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hohlfeld, P" uniqKey="Hohlfeld P">P Hohlfeld</name></author><author><name sortKey="Forestier, F" uniqKey="Forestier F">F Forestier</name></author><author><name sortKey="Kaplan, C" uniqKey="Kaplan C">C Kaplan</name></author><author><name sortKey="Tissot, Jd" uniqKey="Tissot J">JD Tissot</name></author><author><name sortKey="Daffos, F" uniqKey="Daffos F">F Daffos</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ulusoy, E" uniqKey="Ulusoy E">E Ulusoy</name></author><author><name sortKey="Tufekci, O" uniqKey="Tufekci O">O Tüfekçi</name></author><author><name sortKey="Duman, N" uniqKey="Duman N">N Duman</name></author><author><name sortKey="Kumral, A" uniqKey="Kumral A">A Kumral</name></author><author><name sortKey="Irken, G" uniqKey="Irken G">G Irken</name></author><author><name sortKey="Oren, H" uniqKey="Oren H">H Oren</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Jong, Ep" uniqKey="De Jong E">EP de Jong</name></author><author><name sortKey="De Haan, Tr" uniqKey="De Haan T">TR de Haan</name></author><author><name sortKey="Kroes, Ac" uniqKey="Kroes A">AC Kroes</name></author><author><name sortKey="Beersma, Mf" uniqKey="Beersma M">MF Beersma</name></author><author><name sortKey="Oepkes, D" uniqKey="Oepkes D">D Oepkes</name></author><author><name sortKey="Walther, Fj" uniqKey="Walther F">FJ Walther</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chisaka, H" uniqKey="Chisaka H">H Chisaka</name></author><author><name sortKey="Morita, E" uniqKey="Morita E">E Morita</name></author><author><name sortKey="Yaegashi, N" uniqKey="Yaegashi N">N Yaegashi</name></author><author><name sortKey="Sugamura, K" uniqKey="Sugamura K">K Sugamura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hussein, H" uniqKey="Hussein H">H Hussein</name></author><author><name sortKey="Phillips, N" uniqKey="Phillips N">N Phillips</name></author><author><name sortKey="Riste, M" uniqKey="Riste M">M Riste</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bode, Sf" uniqKey="Bode S">SF Bode</name></author><author><name sortKey="Bogdan, C" uniqKey="Bogdan C">C Bogdan</name></author><author><name sortKey="Beutel, K" uniqKey="Beutel K">K Beutel</name></author><author><name sortKey="Behnisch, W" uniqKey="Behnisch W">W Behnisch</name></author><author><name sortKey="Greiner, J" uniqKey="Greiner J">J Greiner</name></author><author><name sortKey="Henning, S" uniqKey="Henning S">S Henning</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zeb, Ja" uniqKey="Zeb J">JA Zeb</name></author><author><name sortKey="Zahid, B" uniqKey="Zahid B">B Zahid</name></author><author><name sortKey="Ahmad, S" uniqKey="Ahmad S">S Ahmad</name></author><author><name sortKey="Gul, Z" uniqKey="Gul Z">Z Gul</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Belen, B" uniqKey="Belen B">B Belen</name></author><author><name sortKey="Hismi, Bo" uniqKey="Hismi B">BO Hismi</name></author><author><name sortKey="Kocak, U" uniqKey="Kocak U">U Kocak</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Erlacher, M" uniqKey="Erlacher M">M Erlacher</name></author><author><name sortKey="Grunert, Sc" uniqKey="Grunert S">SC Grünert</name></author><author><name sortKey="Cseh, A" uniqKey="Cseh A">A Cseh</name></author><author><name sortKey="Steinfeld, R" uniqKey="Steinfeld R">R Steinfeld</name></author><author><name sortKey="Salzer, U" uniqKey="Salzer U">U Salzer</name></author><author><name sortKey="Lausch, E" uniqKey="Lausch E">E Lausch</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ida, H" uniqKey="Ida H">H Ida</name></author><author><name sortKey="Rennert, Om" uniqKey="Rennert O">OM Rennert</name></author><author><name sortKey="Ito, T" uniqKey="Ito T">T Ito</name></author><author><name sortKey="Maekawa, K" uniqKey="Maekawa K">K Maekawa</name></author><author><name sortKey="Eto, Y" uniqKey="Eto Y">Y Eto</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stark, Z" uniqKey="Stark Z">Z Stark</name></author><author><name sortKey="Savarirayan, R" uniqKey="Savarirayan R">R Savarirayan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Alter, Bp" uniqKey="Alter B">BP Alter</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pannicke, U" uniqKey="Pannicke U">U Pannicke</name></author><author><name sortKey="Honig, M" uniqKey="Honig M">M Hönig</name></author><author><name sortKey="Hess, I" uniqKey="Hess I">I Hess</name></author><author><name sortKey="Friesen, C" uniqKey="Friesen C">C Friesen</name></author><author><name sortKey="Holzmann, K" uniqKey="Holzmann K">K Holzmann</name></author><author><name sortKey="Rump, Em" uniqKey="Rump E">EM Rump</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lagresle Peyrou, C" uniqKey="Lagresle Peyrou C">C Lagresle-Peyrou</name></author><author><name sortKey="Six, Em" uniqKey="Six E">EM Six</name></author><author><name sortKey="Picard, C" uniqKey="Picard C">C Picard</name></author><author><name sortKey="Rieux Laucat, F" uniqKey="Rieux Laucat F">F Rieux-Laucat</name></author><author><name sortKey="Michel, V" uniqKey="Michel V">V Michel</name></author><author><name sortKey="Ditadi, A" uniqKey="Ditadi A">A Ditadi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Soulier, J" uniqKey="Soulier J">J Soulier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cervenka, J" uniqKey="Cervenka J">J Cervenka</name></author><author><name sortKey="Arthur, D" uniqKey="Arthur D">D Arthur</name></author><author><name sortKey="Yasis, C" uniqKey="Yasis C">C Yasis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dokal, I" uniqKey="Dokal I">I Dokal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vulliamy, Tj" uniqKey="Vulliamy T">TJ Vulliamy</name></author><author><name sortKey="Marrone, A" uniqKey="Marrone A">A Marrone</name></author><author><name sortKey="Knight, Sw" uniqKey="Knight S">SW Knight</name></author><author><name sortKey="Walne, A" uniqKey="Walne A">A Walne</name></author><author><name sortKey="Mason, Pj" uniqKey="Mason P">PJ Mason</name></author><author><name sortKey="Dokal, I" uniqKey="Dokal I">I Dokal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ceccaldi, R" uniqKey="Ceccaldi R">R Ceccaldi</name></author><author><name sortKey="Briot, D" uniqKey="Briot D">D Briot</name></author><author><name sortKey="Larghero, J" uniqKey="Larghero J">J Larghero</name></author><author><name sortKey="Vasquez, N" uniqKey="Vasquez N">N Vasquez</name></author><author><name sortKey="Dubois D Nghien, C" uniqKey="Dubois D Nghien C">C Dubois d’Enghien</name></author><author><name sortKey="Chamousset, D" uniqKey="Chamousset D">D Chamousset</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bagby, Gc" uniqKey="Bagby G">GC Bagby</name></author><author><name sortKey="Meyers, G" uniqKey="Meyers G">G Meyers</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Alter, Bp" uniqKey="Alter B">BP Alter</name></author><author><name sortKey="Giri, N" uniqKey="Giri N">N Giri</name></author><author><name sortKey="Savage, Sa" uniqKey="Savage S">SA Savage</name></author><author><name sortKey="Peters, Ja" uniqKey="Peters J">JA Peters</name></author><author><name sortKey="Loud, Jt" uniqKey="Loud J">JT Loud</name></author><author><name sortKey="Leathwood, L" uniqKey="Leathwood L">L Leathwood</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rosenberg, Ps" uniqKey="Rosenberg P">PS Rosenberg</name></author><author><name sortKey="Alter, Bp" uniqKey="Alter B">BP Alter</name></author><author><name sortKey="Bolyard, Aa" uniqKey="Bolyard A">AA Bolyard</name></author><author><name sortKey="Bonilla, Ma" uniqKey="Bonilla M">MA Bonilla</name></author><author><name sortKey="Boxer, La" uniqKey="Boxer L">LA Boxer</name></author><author><name sortKey="Cham, B" uniqKey="Cham B">B Cham</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dhanraj, S" uniqKey="Dhanraj S">S Dhanraj</name></author><author><name sortKey="Manji, A" uniqKey="Manji A">A Manji</name></author><author><name sortKey="Pinto, D" uniqKey="Pinto D">D Pinto</name></author><author><name sortKey="Scherer, Sw" uniqKey="Scherer S">SW Scherer</name></author><author><name sortKey="Favre, H" uniqKey="Favre H">H Favre</name></author><author><name sortKey="Loh, Ml" uniqKey="Loh M">ML Loh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tamary, H" uniqKey="Tamary H">H Tamary</name></author><author><name sortKey="Nishri, D" uniqKey="Nishri D">D Nishri</name></author><author><name sortKey="Yacobovich, J" uniqKey="Yacobovich J">J Yacobovich</name></author><author><name sortKey="Zilber, R" uniqKey="Zilber R">R Zilber</name></author><author><name sortKey="Dgany, O" uniqKey="Dgany O">O Dgany</name></author><author><name sortKey="Krasnov, T" uniqKey="Krasnov T">T Krasnov</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Camitta, Bm" uniqKey="Camitta B">BM Camitta</name></author><author><name sortKey="Rock, A" uniqKey="Rock A">A Rock</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vlachos, A" uniqKey="Vlachos A">A Vlachos</name></author><author><name sortKey="Rosenberg, Ps" uniqKey="Rosenberg P">PS Rosenberg</name></author><author><name sortKey="Atsidaftos, E" uniqKey="Atsidaftos E">E Atsidaftos</name></author><author><name sortKey="Alter, Bp" uniqKey="Alter B">BP Alter</name></author><author><name sortKey="Lipton, Jm" uniqKey="Lipton J">JM Lipton</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Taskinen, M" uniqKey="Taskinen M">M Taskinen</name></author><author><name sortKey="Ranki, A" uniqKey="Ranki A">A Ranki</name></author><author><name sortKey="Pukkala, E" uniqKey="Pukkala E">E Pukkala</name></author><author><name sortKey="Jeskanen, L" uniqKey="Jeskanen L">L Jeskanen</name></author><author><name sortKey="Kaitila, I" uniqKey="Kaitila I">I Kaitila</name></author><author><name sortKey="M Kitie, O" uniqKey="M Kitie O">O Mäkitie</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhou, Bb" uniqKey="Zhou B">BB Zhou</name></author><author><name sortKey="Elledge, Sj" uniqKey="Elledge S">SJ Elledge</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ceccaldi, R" uniqKey="Ceccaldi R">R Ceccaldi</name></author><author><name sortKey="Parmar, K" uniqKey="Parmar K">K Parmar</name></author><author><name sortKey="Mouly, E" uniqKey="Mouly E">E Mouly</name></author><author><name sortKey="Delord, M" uniqKey="Delord M">M Delord</name></author><author><name sortKey="Kim, Jm" uniqKey="Kim J">JM Kim</name></author><author><name sortKey="Regairaz, M" uniqKey="Regairaz M">M Regairaz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Pater, E" uniqKey="De Pater E">E de Pater</name></author><author><name sortKey="Kaimakis, P" uniqKey="Kaimakis P">P Kaimakis</name></author><author><name sortKey="Vink, Cs" uniqKey="Vink C">CS Vink</name></author><author><name sortKey="Yokomizo, T" uniqKey="Yokomizo T">T Yokomizo</name></author><author><name sortKey="Yamada Inagawa, T" uniqKey="Yamada Inagawa T">T Yamada-Inagawa</name></author><author><name sortKey="Van Der Linden, R" uniqKey="Van Der Linden R">R van der Linden</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kissa, K" uniqKey="Kissa K">K Kissa</name></author><author><name sortKey="Herbomel, P" uniqKey="Herbomel P">P Herbomel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cazzola, M" uniqKey="Cazzola M">M Cazzola</name></author><author><name sortKey="Della Porta, Mg" uniqKey="Della Porta M">MG Della Porta</name></author><author><name sortKey="Malcovati, L" uniqKey="Malcovati L">L Malcovati</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xie, M" uniqKey="Xie M">M Xie</name></author><author><name sortKey="Lu, C" uniqKey="Lu C">C Lu</name></author><author><name sortKey="Wang, J" uniqKey="Wang J">J Wang</name></author><author><name sortKey="Mclellan, Md" uniqKey="Mclellan M">MD McLellan</name></author><author><name sortKey="Johnson, Kj" uniqKey="Johnson K">KJ Johnson</name></author><author><name sortKey="Wendl, Mc" uniqKey="Wendl M">MC Wendl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hirabayashi, S" uniqKey="Hirabayashi S">S Hirabayashi</name></author><author><name sortKey="Strahm, B" uniqKey="Strahm B">B Strahm</name></author><author><name sortKey="Urbaniak, S" uniqKey="Urbaniak S">S Urbaniak</name></author><author><name sortKey="Karow, A" uniqKey="Karow A">A Karow</name></author><author><name sortKey="Cseh, A" uniqKey="Cseh A">A Cseh</name></author><author><name sortKey="Van Den Heuvel Eibrink, Mm" uniqKey="Van Den Heuvel Eibrink M">MM van den Heuvel-Eibrink</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Michaud, J" uniqKey="Michaud J">J Michaud</name></author><author><name sortKey="Wu, F" uniqKey="Wu F">F Wu</name></author><author><name sortKey="Osato, M" uniqKey="Osato M">M Osato</name></author><author><name sortKey="Cottles, Gm" uniqKey="Cottles G">GM Cottles</name></author><author><name sortKey="Yanagida, M" uniqKey="Yanagida M">M Yanagida</name></author><author><name sortKey="Asou, N" uniqKey="Asou N">N Asou</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Den Heuvel Eibrink, Mm" uniqKey="Van Den Heuvel Eibrink M">MM van den Heuvel-Eibrink</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Katagiri, T" uniqKey="Katagiri T">T Katagiri</name></author><author><name sortKey="Sato Otsubo, A" uniqKey="Sato Otsubo A">A Sato-Otsubo</name></author><author><name sortKey="Kashiwase, K" uniqKey="Kashiwase K">K Kashiwase</name></author><author><name sortKey="Morishima, S" uniqKey="Morishima S">S Morishima</name></author><author><name sortKey="Sato, Y" uniqKey="Sato Y">Y Sato</name></author><author><name sortKey="Mori, Y" uniqKey="Mori Y">Y Mori</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kulasekararaj, Ag" uniqKey="Kulasekararaj A">AG Kulasekararaj</name></author><author><name sortKey="Jiang, J" uniqKey="Jiang J">J Jiang</name></author><author><name sortKey="Smith, Ae" uniqKey="Smith A">AE Smith</name></author><author><name sortKey="Mohamedali, Am" uniqKey="Mohamedali A">AM Mohamedali</name></author><author><name sortKey="Mian, S" uniqKey="Mian S">S Mian</name></author><author><name sortKey="Gandhi, S" uniqKey="Gandhi S">S Gandhi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Korthof, Et" uniqKey="Korthof E">ET Korthof</name></author><author><name sortKey="Svahn, J" uniqKey="Svahn J">J Svahn</name></author><author><name sortKey="Peffault De Latour, R" uniqKey="Peffault De Latour R">R Peffault de Latour</name></author><author><name sortKey="Terranova, P" uniqKey="Terranova P">P Terranova</name></author><author><name sortKey="Moins Teisserenc, H" uniqKey="Moins Teisserenc H">H Moins-Teisserenc</name></author><author><name sortKey="Socie, G" uniqKey="Socie G">G Socié</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Epling Burnette, Pk" uniqKey="Epling Burnette P">PK Epling-Burnette</name></author><author><name sortKey="Painter, Js" uniqKey="Painter J">JS Painter</name></author><author><name sortKey="Rollison, De" uniqKey="Rollison D">DE Rollison</name></author><author><name sortKey="Ku, E" uniqKey="Ku E">E Ku</name></author><author><name sortKey="Vendron, D" uniqKey="Vendron D">D Vendron</name></author><author><name sortKey="Widen, R" uniqKey="Widen R">R Widen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Vries, Ac" uniqKey="De Vries A">AC de Vries</name></author><author><name sortKey="Langerak, Aw" uniqKey="Langerak A">AW Langerak</name></author><author><name sortKey="Verhaaf, B" uniqKey="Verhaaf B">B Verhaaf</name></author><author><name sortKey="Niemeyer, Cm" uniqKey="Niemeyer C">CM Niemeyer</name></author><author><name sortKey="Stary, J" uniqKey="Stary J">J Stary</name></author><author><name sortKey="Schmiegelow, K" uniqKey="Schmiegelow K">K Schmiegelow</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Giannouli, S" uniqKey="Giannouli S">S Giannouli</name></author><author><name sortKey="Voulgarelis, M" uniqKey="Voulgarelis M">M Voulgarelis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshimi, A" uniqKey="Yoshimi A">A Yoshimi</name></author><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author><author><name sortKey="Fuhrer, M" uniqKey="Fuhrer M">M Führer</name></author><author><name sortKey="Bergstr Sser, E" uniqKey="Bergstr Sser E">E Bergsträsser</name></author><author><name sortKey="Gobel, U" uniqKey="Gobel U">U Göbel</name></author><author><name sortKey="Sykora, Kw" uniqKey="Sykora K">KW Sykora</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zeng, Y" uniqKey="Zeng Y">Y Zeng</name></author><author><name sortKey="Katsanis, E" uniqKey="Katsanis E">E Katsanis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kordasti, S" uniqKey="Kordasti S">S Kordasti</name></author><author><name sortKey="Marsh, J" uniqKey="Marsh J">J Marsh</name></author><author><name sortKey="Al Khan, S" uniqKey="Al Khan S">S Al-Khan</name></author><author><name sortKey="Jiang, J" uniqKey="Jiang J">J Jiang</name></author><author><name sortKey="Smith, A" uniqKey="Smith A">A Smith</name></author><author><name sortKey="Mohamedali, A" uniqKey="Mohamedali A">A Mohamedali</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, C" uniqKey="Chen C">C Chen</name></author><author><name sortKey="Lu, S" uniqKey="Lu S">S Lu</name></author><author><name sortKey="Luo, M" uniqKey="Luo M">M Luo</name></author><author><name sortKey="Zhang, B" uniqKey="Zhang B">B Zhang</name></author><author><name sortKey="Xiao, L" uniqKey="Xiao L">L Xiao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fuhrer, M" uniqKey="Fuhrer M">M Führer</name></author><author><name sortKey="Durner, J" uniqKey="Durner J">J Durner</name></author><author><name sortKey="Brunnler, G" uniqKey="Brunnler G">G Brünnler</name></author><author><name sortKey="Gotte, H" uniqKey="Gotte H">H Götte</name></author><author><name sortKey="Deppner, C" uniqKey="Deppner C">C Deppner</name></author><author><name sortKey="Bender Gotze, C" uniqKey="Bender Gotze C">C Bender-Götze</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hirano, N" uniqKey="Hirano N">N Hirano</name></author><author><name sortKey="Butler, Mo" uniqKey="Butler M">MO Butler</name></author><author><name sortKey="Von Bergwelt Baildon, Ms" uniqKey="Von Bergwelt Baildon M">MS Von Bergwelt-Baildon</name></author><author><name sortKey="Maecker, B" uniqKey="Maecker B">B Maecker</name></author><author><name sortKey="Schultze, Jl" uniqKey="Schultze J">JL Schultze</name></author><author><name sortKey="O Onnor, Kc" uniqKey="O Onnor K">KC O’Connor</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takamatsu, H" uniqKey="Takamatsu H">H Takamatsu</name></author><author><name sortKey="Espinoza, Jl" uniqKey="Espinoza J">JL Espinoza</name></author><author><name sortKey="Lu, X" uniqKey="Lu X">X Lu</name></author><author><name sortKey="Qi, Z" uniqKey="Qi Z">Z Qi</name></author><author><name sortKey="Okawa, K" uniqKey="Okawa K">K Okawa</name></author><author><name sortKey="Nakao, S" uniqKey="Nakao S">S Nakao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Young, Ns" uniqKey="Young N">NS Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fuhrer, M" uniqKey="Fuhrer M">M Führer</name></author><author><name sortKey="Rampf, U" uniqKey="Rampf U">U Rampf</name></author><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author><author><name sortKey="Faldum, A" uniqKey="Faldum A">A Faldum</name></author><author><name sortKey="Niemeyer, C" uniqKey="Niemeyer C">C Niemeyer</name></author><author><name sortKey="Janka Schaub, G" uniqKey="Janka Schaub G">G Janka-Schaub</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Walter, D" uniqKey="Walter D">D Walter</name></author><author><name sortKey="Lier, A" uniqKey="Lier A">A Lier</name></author><author><name sortKey="Geiselhart, A" uniqKey="Geiselhart A">A Geiselhart</name></author><author><name sortKey="Thalheimer, Fb" uniqKey="Thalheimer F">FB Thalheimer</name></author><author><name sortKey="Huntscha, S" uniqKey="Huntscha S">S Huntscha</name></author><author><name sortKey="Sobotta, Mc" uniqKey="Sobotta M">MC Sobotta</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pietras, Em" uniqKey="Pietras E">EM Pietras</name></author><author><name sortKey="Lakshminarasimhan, R" uniqKey="Lakshminarasimhan R">R Lakshminarasimhan</name></author><author><name sortKey="Techner, Jm" uniqKey="Techner J">JM Techner</name></author><author><name sortKey="Fong, S" uniqKey="Fong S">S Fong</name></author><author><name sortKey="Flach, J" uniqKey="Flach J">J Flach</name></author><author><name sortKey="Binnewies, M" uniqKey="Binnewies M">M Binnewies</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bulycheva, E" uniqKey="Bulycheva E">E Bulycheva</name></author><author><name sortKey="Rauner, M" uniqKey="Rauner M">M Rauner</name></author><author><name sortKey="Medyouf, H" uniqKey="Medyouf H">H Medyouf</name></author><author><name sortKey="Theurl, I" uniqKey="Theurl I">I Theurl</name></author><author><name sortKey="Bornh User, M" uniqKey="Bornh User M">M Bornhäuser</name></author><author><name sortKey="Hofbauer, Lc" uniqKey="Hofbauer L">LC Hofbauer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author><author><name sortKey="Zhao, Q" uniqKey="Zhao Q">Q Zhao</name></author><author><name sortKey="Xing, W" uniqKey="Xing W">W Xing</name></author><author><name sortKey="Feng, J" uniqKey="Feng J">J Feng</name></author><author><name sortKey="Wu, H" uniqKey="Wu H">H Wu</name></author><author><name sortKey="Li, H" uniqKey="Li H">H Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sloand, E" uniqKey="Sloand E">E Sloand</name></author><author><name sortKey="Kim, S" uniqKey="Kim S">S Kim</name></author><author><name sortKey="Maciejewski, Jp" uniqKey="Maciejewski J">JP Maciejewski</name></author><author><name sortKey="Tisdale, J" uniqKey="Tisdale J">J Tisdale</name></author><author><name sortKey="Follmann, D" uniqKey="Follmann D">D Follmann</name></author><author><name sortKey="Young, Ns" uniqKey="Young N">NS Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, Cy" uniqKey="Liu C">CY Liu</name></author><author><name sortKey="Fu, R" uniqKey="Fu R">R Fu</name></author><author><name sortKey="Wang, Hq" uniqKey="Wang H">HQ Wang</name></author><author><name sortKey="Li, Lj" uniqKey="Li L">LJ Li</name></author><author><name sortKey="Liu, H" uniqKey="Liu H">H Liu</name></author><author><name sortKey="Guan, J" uniqKey="Guan J">J Guan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Balakumaran, A" uniqKey="Balakumaran A">A Balakumaran</name></author><author><name sortKey="Mishra, Pj" uniqKey="Mishra P">PJ Mishra</name></author><author><name sortKey="Pawelczyk, E" uniqKey="Pawelczyk E">E Pawelczyk</name></author><author><name sortKey="Yoshizawa, S" uniqKey="Yoshizawa S">S Yoshizawa</name></author><author><name sortKey="Sworder, Bj" uniqKey="Sworder B">BJ Sworder</name></author><author><name sortKey="Cherman, N" uniqKey="Cherman N">N Cherman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lecourt, S" uniqKey="Lecourt S">S Lecourt</name></author><author><name sortKey="Vanneaux, V" uniqKey="Vanneaux V">V Vanneaux</name></author><author><name sortKey="Leblanc, T" uniqKey="Leblanc T">T Leblanc</name></author><author><name sortKey="Leroux, G" uniqKey="Leroux G">G Leroux</name></author><author><name sortKey="Ternaux, B" uniqKey="Ternaux B">B Ternaux</name></author><author><name sortKey="Benbunan, M" uniqKey="Benbunan M">M Benbunan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Santamaria, C" uniqKey="Santamaria C">C Santamaría</name></author><author><name sortKey="Munti N, S" uniqKey="Munti N S">S Muntión</name></author><author><name sortKey="Ros N, B" uniqKey="Ros N B">B Rosón</name></author><author><name sortKey="Blanco, B" uniqKey="Blanco B">B Blanco</name></author><author><name sortKey="L Pez Villar, O" uniqKey="L Pez Villar O">O López-Villar</name></author><author><name sortKey="Carrancio, S" uniqKey="Carrancio S">S Carrancio</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Raaijmakers, Mh" uniqKey="Raaijmakers M">MH Raaijmakers</name></author><author><name sortKey="Mukherjee, S" uniqKey="Mukherjee S">S Mukherjee</name></author><author><name sortKey="Guo, S" uniqKey="Guo S">S Guo</name></author><author><name sortKey="Zhang, S" uniqKey="Zhang S">S Zhang</name></author><author><name sortKey="Kobayashi, T" uniqKey="Kobayashi T">T Kobayashi</name></author><author><name sortKey="Schoonmaker, Ja" uniqKey="Schoonmaker J">JA Schoonmaker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Medyouf, H" uniqKey="Medyouf H">H Medyouf</name></author><author><name sortKey="Mossner, M" uniqKey="Mossner M">M Mossner</name></author><author><name sortKey="Jann, Jc" uniqKey="Jann J">JC Jann</name></author><author><name sortKey="Nolte, F" uniqKey="Nolte F">F Nolte</name></author><author><name sortKey="Raffel, S" uniqKey="Raffel S">S Raffel</name></author><author><name sortKey="Herrmann, C" uniqKey="Herrmann C">C Herrmann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="O Riscoll, M" uniqKey="O Riscoll M">M O’Driscoll</name></author><author><name sortKey="Ruiz Perez, Vl" uniqKey="Ruiz Perez V">VL Ruiz-Perez</name></author><author><name sortKey="Woods, Cg" uniqKey="Woods C">CG Woods</name></author><author><name sortKey="Jeggo, Pa" uniqKey="Jeggo P">PA Jeggo</name></author><author><name sortKey="Goodship, Ja" uniqKey="Goodship J">JA Goodship</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Seneca, S" uniqKey="Seneca S">S Seneca</name></author><author><name sortKey="De Meirleir, L" uniqKey="De Meirleir L">L De Meirleir</name></author><author><name sortKey="De Schepper, J" uniqKey="De Schepper J">J De Schepper</name></author><author><name sortKey="Balduck, N" uniqKey="Balduck N">N Balduck</name></author><author><name sortKey="Jochmans, K" uniqKey="Jochmans K">K Jochmans</name></author><author><name sortKey="Liebaers, I" uniqKey="Liebaers I">I Liebaers</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shimamura, A" uniqKey="Shimamura A">A Shimamura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Corey, Sj" uniqKey="Corey S">SJ Corey</name></author><author><name sortKey="Minden, Md" uniqKey="Minden M">MD Minden</name></author><author><name sortKey="Barber, Dl" uniqKey="Barber D">DL Barber</name></author><author><name sortKey="Kantarjian, H" uniqKey="Kantarjian H">H Kantarjian</name></author><author><name sortKey="Wang, Jc" uniqKey="Wang J">JC Wang</name></author><author><name sortKey="Schimmer, Ad" uniqKey="Schimmer A">AD Schimmer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Parker, Je" uniqKey="Parker J">JE Parker</name></author><author><name sortKey="Mufti, Gj" uniqKey="Mufti G">GJ Mufti</name></author><author><name sortKey="Rasool, F" uniqKey="Rasool F">F Rasool</name></author><author><name sortKey="Mijovic, A" uniqKey="Mijovic A">A Mijovic</name></author><author><name sortKey="Devereux, S" uniqKey="Devereux S">S Devereux</name></author><author><name sortKey="Pagliuca, A" uniqKey="Pagliuca A">A Pagliuca</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jaffe, Es" uniqKey="Jaffe E">ES Jaffe</name></author><author><name sortKey="Harris, Nl" uniqKey="Harris N">NL Harris</name></author><author><name sortKey="Stein, H" uniqKey="Stein H">H Stein</name></author><author><name sortKey="Vardiman, Jw" uniqKey="Vardiman J">JW. Vardiman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hasle, H" uniqKey="Hasle H">H Hasle</name></author><author><name sortKey="Niemeyer, Cm" uniqKey="Niemeyer C">CM Niemeyer</name></author><author><name sortKey="Chessells, Jm" uniqKey="Chessells J">JM Chessells</name></author><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author><author><name sortKey="Bennett, Jm" uniqKey="Bennett J">JM Bennett</name></author><author><name sortKey="Kerndrup, G" uniqKey="Kerndrup G">G Kerndrup</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Niemeyer, Cm" uniqKey="Niemeyer C">CM Niemeyer</name></author><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Luna Fineman, S" uniqKey="Luna Fineman S">S Luna-Fineman</name></author><author><name sortKey="Shannon, Km" uniqKey="Shannon K">KM Shannon</name></author><author><name sortKey="Atwater, Sk" uniqKey="Atwater S">SK Atwater</name></author><author><name sortKey="Davis, J" uniqKey="Davis J">J Davis</name></author><author><name sortKey="Masterson, M" uniqKey="Masterson M">M Masterson</name></author><author><name sortKey="Ortega, J" uniqKey="Ortega J">J Ortega</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Passmore, Sj" uniqKey="Passmore S">SJ Passmore</name></author><author><name sortKey="Chessells, Jm" uniqKey="Chessells J">JM Chessells</name></author><author><name sortKey="Kempski, H" uniqKey="Kempski H">H Kempski</name></author><author><name sortKey="Hann, Im" uniqKey="Hann I">IM Hann</name></author><author><name sortKey="Brownbill, Pa" uniqKey="Brownbill P">PA Brownbill</name></author><author><name sortKey="Stiller, Ca" uniqKey="Stiller C">CA Stiller</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gohring, G" uniqKey="Gohring G">G Göhring</name></author><author><name sortKey="Michalova, K" uniqKey="Michalova K">K Michalova</name></author><author><name sortKey="Beverloo, Hb" uniqKey="Beverloo H">HB Beverloo</name></author><author><name sortKey="Betts, D" uniqKey="Betts D">D Betts</name></author><author><name sortKey="Harbott, J" uniqKey="Harbott J">J Harbott</name></author><author><name sortKey="Haas, Oa" uniqKey="Haas O">OA Haas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kardos, G" uniqKey="Kardos G">G Kardos</name></author><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author><author><name sortKey="Passmore, Sj" uniqKey="Passmore S">SJ Passmore</name></author><author><name sortKey="Locatelli, F" uniqKey="Locatelli F">F Locatelli</name></author><author><name sortKey="Hasle, H" uniqKey="Hasle H">H Hasle</name></author><author><name sortKey="Schultz, Kr" uniqKey="Schultz K">KR Schultz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mantadakis, E" uniqKey="Mantadakis E">E Mantadakis</name></author><author><name sortKey="Shannon, Km" uniqKey="Shannon K">KM Shannon</name></author><author><name sortKey="Singer, Da" uniqKey="Singer D">DA Singer</name></author><author><name sortKey="Finklestein, J" uniqKey="Finklestein J">J Finklestein</name></author><author><name sortKey="Chan, Kw" uniqKey="Chan K">KW Chan</name></author><author><name sortKey="Hilden, Jm" uniqKey="Hilden J">JM Hilden</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="West, Ah" uniqKey="West A">AH West</name></author><author><name sortKey="Godley, La" uniqKey="Godley L">LA Godley</name></author><author><name sortKey="Churpek, Je" uniqKey="Churpek J">JE Churpek</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Collin, M" uniqKey="Collin M">M Collin</name></author><author><name sortKey="Dickinson, R" uniqKey="Dickinson R">R Dickinson</name></author><author><name sortKey="Bigley, V" uniqKey="Bigley V">V Bigley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gluckman, E" uniqKey="Gluckman E">E Gluckman</name></author><author><name sortKey="Marmont, A" uniqKey="Marmont A">A Marmont</name></author><author><name sortKey="Speck, B" uniqKey="Speck B">B Speck</name></author><author><name sortKey="Gordon Smith, Ec" uniqKey="Gordon Smith E">EC Gordon-Smith</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Speck, B" uniqKey="Speck B">B Speck</name></author><author><name sortKey="Cornu, P" uniqKey="Cornu P">P Cornu</name></author><author><name sortKey="Jeannet, M" uniqKey="Jeannet M">M Jeannet</name></author><author><name sortKey="Nissen, C" uniqKey="Nissen C">C Nissen</name></author><author><name sortKey="Burri, Hp" uniqKey="Burri H">HP Burri</name></author><author><name sortKey="Groff, P" uniqKey="Groff P">P Groff</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ren, J" uniqKey="Ren J">J Ren</name></author><author><name sortKey="Hou, Xy" uniqKey="Hou X">XY Hou</name></author><author><name sortKey="Ma, Sh" uniqKey="Ma S">SH Ma</name></author><author><name sortKey="Zhang, Fk" uniqKey="Zhang F">FK Zhang</name></author><author><name sortKey="Zhen, Jh" uniqKey="Zhen J">JH Zhen</name></author><author><name sortKey="Sun, L" uniqKey="Sun L">L Sun</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kochenderfer, Jn" uniqKey="Kochenderfer J">JN Kochenderfer</name></author><author><name sortKey="Kobayashi, S" uniqKey="Kobayashi S">S Kobayashi</name></author><author><name sortKey="Wieder, Ed" uniqKey="Wieder E">ED Wieder</name></author><author><name sortKey="Su, C" uniqKey="Su C">C Su</name></author><author><name sortKey="Molldrem, Jj" uniqKey="Molldrem J">JJ Molldrem</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wlodarski, Mw" uniqKey="Wlodarski M">MW Wlodarski</name></author><author><name sortKey="Gondek, Lp" uniqKey="Gondek L">LP Gondek</name></author><author><name sortKey="Nearman, Zp" uniqKey="Nearman Z">ZP Nearman</name></author><author><name sortKey="Plasilova, M" uniqKey="Plasilova M">M Plasilova</name></author><author><name sortKey="Kalaycio, M" uniqKey="Kalaycio M">M Kalaycio</name></author><author><name sortKey="Hsi, Ed" uniqKey="Hsi E">ED Hsi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zeng, W" uniqKey="Zeng W">W Zeng</name></author><author><name sortKey="Maciejewski, Jp" uniqKey="Maciejewski J">JP Maciejewski</name></author><author><name sortKey="Chen, G" uniqKey="Chen G">G Chen</name></author><author><name sortKey="Young, Ns" uniqKey="Young N">NS Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Risitano, Am" uniqKey="Risitano A">AM Risitano</name></author><author><name sortKey="Maciejewski, Jp" uniqKey="Maciejewski J">JP Maciejewski</name></author><author><name sortKey="Green, S" uniqKey="Green S">S Green</name></author><author><name sortKey="Plasilova, M" uniqKey="Plasilova M">M Plasilova</name></author><author><name sortKey="Zeng, W" uniqKey="Zeng W">W Zeng</name></author><author><name sortKey="Young, Ns" uniqKey="Young N">NS Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xing, L" uniqKey="Xing L">L Xing</name></author><author><name sortKey="Liu, C" uniqKey="Liu C">C Liu</name></author><author><name sortKey="Fu, R" uniqKey="Fu R">R Fu</name></author><author><name sortKey="Wang, H" uniqKey="Wang H">H Wang</name></author><author><name sortKey="Wang, J" uniqKey="Wang J">J Wang</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Babushok, Dv" uniqKey="Babushok D">DV Babushok</name></author><author><name sortKey="Perdigones, N" uniqKey="Perdigones N">N Perdigones</name></author><author><name sortKey="Perin, Jc" uniqKey="Perin J">JC Perin</name></author><author><name sortKey="Olson, Ts" uniqKey="Olson T">TS Olson</name></author><author><name sortKey="Ye, W" uniqKey="Ye W">W Ye</name></author><author><name sortKey="Roth, Jj" uniqKey="Roth J">JJ Roth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hasle, H" uniqKey="Hasle H">H Hasle</name></author><author><name sortKey="Heim, S" uniqKey="Heim S">S Heim</name></author><author><name sortKey="Schroeder, H" uniqKey="Schroeder H">H Schroeder</name></author><author><name sortKey="Schmiegelow, K" uniqKey="Schmiegelow K">K Schmiegelow</name></author><author><name sortKey="Ostergaard, E" uniqKey="Ostergaard E">E Ostergaard</name></author><author><name sortKey="Kerndrup, G" uniqKey="Kerndrup G">G Kerndrup</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Villarreal Martinez, L" uniqKey="Villarreal Martinez L">L Villarreal-Martinez</name></author><author><name sortKey="Jaime Perez, Jc" uniqKey="Jaime Perez J">JC Jaime-Perez</name></author><author><name sortKey="Rodriguez Martinez, M" uniqKey="Rodriguez Martinez M">M Rodriguez-Martinez</name></author><author><name sortKey="Gonzalez Llano, O" uniqKey="Gonzalez Llano O">O Gonzalez-Llano</name></author><author><name sortKey="Gomez Almaguer, D" uniqKey="Gomez Almaguer D">D Gomez-Almaguer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author><author><name sortKey="Fuhrer, M" uniqKey="Fuhrer M">M Führer</name></author><author><name sortKey="Behrendt, S" uniqKey="Behrendt S">S Behrendt</name></author><author><name sortKey="Campr, V" uniqKey="Campr V">V Campr</name></author><author><name sortKey="Csomor, J" uniqKey="Csomor J">J Csomor</name></author><author><name sortKey="Furlan, I" uniqKey="Furlan I">I Furlan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yamaguchi, H" uniqKey="Yamaguchi H">H Yamaguchi</name></author><author><name sortKey="Calado, Rt" uniqKey="Calado R">RT Calado</name></author><author><name sortKey="Ly, H" uniqKey="Ly H">H Ly</name></author><author><name sortKey="Kajigaya, S" uniqKey="Kajigaya S">S Kajigaya</name></author><author><name sortKey="Baerlocher, Gm" uniqKey="Baerlocher G">GM Baerlocher</name></author><author><name sortKey="Chanock, Sj" uniqKey="Chanock S">SJ Chanock</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fibbe, We" uniqKey="Fibbe W">WE Fibbe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dumitriu, B" uniqKey="Dumitriu B">B Dumitriu</name></author><author><name sortKey="Feng, X" uniqKey="Feng X">X Feng</name></author><author><name sortKey="Townsley, Dm" uniqKey="Townsley D">DM Townsley</name></author><author><name sortKey="Ueda, Y" uniqKey="Ueda Y">Y Ueda</name></author><author><name sortKey="Yoshizato, T" uniqKey="Yoshizato T">T Yoshizato</name></author><author><name sortKey="Calado, Rt" uniqKey="Calado R">RT Calado</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Welte, K" uniqKey="Welte K">K Welte</name></author><author><name sortKey="Zeidler, C" uniqKey="Zeidler C">C Zeidler</name></author><author><name sortKey="Reiter, A" uniqKey="Reiter A">A Reiter</name></author><author><name sortKey="Muller, W" uniqKey="Muller W">W Müller</name></author><author><name sortKey="Odenwald, E" uniqKey="Odenwald E">E Odenwald</name></author><author><name sortKey="Souza, L" uniqKey="Souza L">L Souza</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Connelly, Ja" uniqKey="Connelly J">JA Connelly</name></author><author><name sortKey="Choi, Sw" uniqKey="Choi S">SW Choi</name></author><author><name sortKey="Levine, Je" uniqKey="Levine J">JE Levine</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zimmer, J" uniqKey="Zimmer J">J Zimmer</name></author><author><name sortKey="Hentges, F" uniqKey="Hentges F">F Hentges</name></author><author><name sortKey="Andres, E" uniqKey="Andres E">E Andres</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Olnes, Mj" uniqKey="Olnes M">MJ Olnes</name></author><author><name sortKey="Scheinberg, P" uniqKey="Scheinberg P">P Scheinberg</name></author><author><name sortKey="Calvo, Kr" uniqKey="Calvo K">KR Calvo</name></author><author><name sortKey="Desmond, R" uniqKey="Desmond R">R Desmond</name></author><author><name sortKey="Tang, Y" uniqKey="Tang Y">Y Tang</name></author><author><name sortKey="Dumitriu, B" uniqKey="Dumitriu B">B Dumitriu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Islam, A" uniqKey="Islam A">A Islam</name></author><author><name sortKey="Rafiq, S" uniqKey="Rafiq S">S Rafiq</name></author><author><name sortKey="Kirwan, M" uniqKey="Kirwan M">M Kirwan</name></author><author><name sortKey="Walne, A" uniqKey="Walne A">A Walne</name></author><author><name sortKey="Cavenagh, J" uniqKey="Cavenagh J">J Cavenagh</name></author><author><name sortKey="Vulliamy, T" uniqKey="Vulliamy T">T Vulliamy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Scheckenbach, K" uniqKey="Scheckenbach K">K Scheckenbach</name></author><author><name sortKey="Morgan, M" uniqKey="Morgan M">M Morgan</name></author><author><name sortKey="Filger Brillinger, J" uniqKey="Filger Brillinger J">J Filger-Brillinger</name></author><author><name sortKey="Sandmann, M" uniqKey="Sandmann M">M Sandmann</name></author><author><name sortKey="Strimling, B" uniqKey="Strimling B">B Strimling</name></author><author><name sortKey="Scheurlen, W" uniqKey="Scheurlen W">W Scheurlen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jaime Perez, Jc" uniqKey="Jaime Perez J">JC Jaime-Pérez</name></author><author><name sortKey="Colunga Pedraza, Pr" uniqKey="Colunga Pedraza P">PR Colunga-Pedraza</name></author><author><name sortKey="G Mez Ramirez, Cd" uniqKey="G Mez Ramirez C">CD Gómez-Ramírez</name></author><author><name sortKey="Gutierrez Aguirre, Ch" uniqKey="Gutierrez Aguirre C">CH Gutiérrez-Aguirre</name></author><author><name sortKey="Cantu Rodriguez, Og" uniqKey="Cantu Rodriguez O">OG Cantú-Rodríguez</name></author><author><name sortKey="Tarin Arzaga, Lc" uniqKey="Tarin Arzaga L">LC Tarín-Arzaga</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rose, Sr" uniqKey="Rose S">SR Rose</name></author><author><name sortKey="Kim, Mo" uniqKey="Kim M">MO Kim</name></author><author><name sortKey="Korbee, L" uniqKey="Korbee L">L Korbee</name></author><author><name sortKey="Wilson, Ka" uniqKey="Wilson K">KA Wilson</name></author><author><name sortKey="Ris, Md" uniqKey="Ris M">MD Ris</name></author><author><name sortKey="Eyal, O" uniqKey="Eyal O">O Eyal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Samarasinghe, S" uniqKey="Samarasinghe S">S Samarasinghe</name></author><author><name sortKey="Marsh, J" uniqKey="Marsh J">J Marsh</name></author><author><name sortKey="Dufour, C" uniqKey="Dufour C">C Dufour</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Scheinberg, P" uniqKey="Scheinberg P">P Scheinberg</name></author><author><name sortKey="Nunez, O" uniqKey="Nunez O">O Nunez</name></author><author><name sortKey="Weinstein, B" uniqKey="Weinstein B">B Weinstein</name></author><author><name sortKey="Scheinberg, P" uniqKey="Scheinberg P">P Scheinberg</name></author><author><name sortKey="Biancotto, A" uniqKey="Biancotto A">A Biancotto</name></author><author><name sortKey="Wu, Co" uniqKey="Wu C">CO Wu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Marsh, Jc" uniqKey="Marsh J">JC Marsh</name></author><author><name sortKey="Bacigalupo, A" uniqKey="Bacigalupo A">A Bacigalupo</name></author><author><name sortKey="Schrezenmeier, H" uniqKey="Schrezenmeier H">H Schrezenmeier</name></author><author><name sortKey="Tichelli, A" uniqKey="Tichelli A">A Tichelli</name></author><author><name sortKey="Risitano, Am" uniqKey="Risitano A">AM Risitano</name></author><author><name sortKey="Passweg, Jr" uniqKey="Passweg J">JR Passweg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshimi, A" uniqKey="Yoshimi A">A Yoshimi</name></author><author><name sortKey="Niemeyer, Cm" uniqKey="Niemeyer C">CM Niemeyer</name></author><author><name sortKey="Fuhrer, Mm" uniqKey="Fuhrer M">MM Fuhrer</name></author><author><name sortKey="Strahm, B" uniqKey="Strahm B">B Strahm</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sloand, Em" uniqKey="Sloand E">EM Sloand</name></author><author><name sortKey="Wu, Co" uniqKey="Wu C">CO Wu</name></author><author><name sortKey="Greenberg, P" uniqKey="Greenberg P">P Greenberg</name></author><author><name sortKey="Young, N" uniqKey="Young N">N Young</name></author><author><name sortKey="Barrett, J" uniqKey="Barrett J">J Barrett</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshimi, A" uniqKey="Yoshimi A">A Yoshimi</name></author><author><name sortKey="Van Den Heuvel Eibrink, Mm" uniqKey="Van Den Heuvel Eibrink M">MM van den Heuvel-Eibrink</name></author><author><name sortKey="Baumann, I" uniqKey="Baumann I">I Baumann</name></author><author><name sortKey="Schwarz, S" uniqKey="Schwarz S">S Schwarz</name></author><author><name sortKey="Simonitsch Klupp, I" uniqKey="Simonitsch Klupp I">I Simonitsch-Klupp</name></author><author><name sortKey="De Paepe, P" uniqKey="De Paepe P">P de Paepe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hasegawa, D" uniqKey="Hasegawa D">D Hasegawa</name></author><author><name sortKey="Manabe, A" uniqKey="Manabe A">A Manabe</name></author><author><name sortKey="Yagasaki, H" uniqKey="Yagasaki H">H Yagasaki</name></author><author><name sortKey="Ohtsuka, Y" uniqKey="Ohtsuka Y">Y Ohtsuka</name></author><author><name sortKey="Inoue, M" uniqKey="Inoue M">M Inoue</name></author><author><name sortKey="Kikuchi, A" uniqKey="Kikuchi A">A Kikuchi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Locatelli, F" uniqKey="Locatelli F">F Locatelli</name></author><author><name sortKey="Porta, F" uniqKey="Porta F">F Porta</name></author><author><name sortKey="Zecca, M" uniqKey="Zecca M">M Zecca</name></author><author><name sortKey="Pedrazzoli, P" uniqKey="Pedrazzoli P">P Pedrazzoli</name></author><author><name sortKey="Maccario, R" uniqKey="Maccario R">R Maccario</name></author><author><name sortKey="Giani, S" uniqKey="Giani S">S Giani</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Samarasinghe, S" uniqKey="Samarasinghe S">S Samarasinghe</name></author><author><name sortKey="Steward, C" uniqKey="Steward C">C Steward</name></author><author><name sortKey="Hiwarkar, P" uniqKey="Hiwarkar P">P Hiwarkar</name></author><author><name sortKey="Saif, Ma" uniqKey="Saif M">MA Saif</name></author><author><name sortKey="Hough, R" uniqKey="Hough R">R Hough</name></author><author><name sortKey="Webb, D" uniqKey="Webb D">D Webb</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Maury, S" uniqKey="Maury S">S Maury</name></author><author><name sortKey="Balere Appert, Ml" uniqKey="Balere Appert M">ML Balère-Appert</name></author><author><name sortKey="Pollichieni, S" uniqKey="Pollichieni S">S Pollichieni</name></author><author><name sortKey="Oneto, R" uniqKey="Oneto R">R Oneto</name></author><author><name sortKey="Yakoub Agha, I" uniqKey="Yakoub Agha I">I Yakoub-Agha</name></author><author><name sortKey="Locatelli, F" uniqKey="Locatelli F">F Locatelli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fuhrer, M" uniqKey="Fuhrer M">M Fuhrer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Strahm, B" uniqKey="Strahm B">B Strahm</name></author><author><name sortKey="Locatelli, F" uniqKey="Locatelli F">F Locatelli</name></author><author><name sortKey="Bader, P" uniqKey="Bader P">P Bader</name></author><author><name sortKey="Ehlert, K" uniqKey="Ehlert K">K Ehlert</name></author><author><name sortKey="Kremens, B" uniqKey="Kremens B">B Kremens</name></author><author><name sortKey="Zintl, F" uniqKey="Zintl F">F Zintl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Strahm, B" uniqKey="Strahm B">B Strahm</name></author><author><name sortKey="Nollke, P" uniqKey="Nollke P">P Nöllke</name></author><author><name sortKey="Zecca, M" uniqKey="Zecca M">M Zecca</name></author><author><name sortKey="Korthof, Et" uniqKey="Korthof E">ET Korthof</name></author><author><name sortKey="Bierings, M" uniqKey="Bierings M">M Bierings</name></author><author><name sortKey="Furlan, I" uniqKey="Furlan I">I Furlan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Macmillan, Ml" uniqKey="Macmillan M">ML MacMillan</name></author><author><name sortKey="Wagner, Je" uniqKey="Wagner J">JE Wagner</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id><journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group><journal-title>Frontiers in Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2296-2360</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26217651</article-id><article-id pub-id-type="pmc">4500095</article-id><article-id pub-id-type="doi">10.3389/fped.2015.00064</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pediatrics</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Erlacher</surname><given-names>Miriam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/203320"></uri></contrib><contrib contrib-type="author"><name><surname>Strahm</surname><given-names>Brigitte</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></aff><aff id="aff2"><sup>2</sup><institution>Freiburg Institute for Advanced Studies, University of Freiburg</institution>,<addr-line>Freiburg</addr-line>,<country>Germany</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Markus G. Seidel, Medical University Graz, Austria</p></fn><fn fn-type="edited-by"><p>Reviewed by: Jan-Henning Klusmann, Hannover Medical School, Germany; Milen Minkov, Rudolfstiftung Hospital, Austria</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Brigitte Strahm, Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center of Freiburg, Mathildenstr. 1, Freiburg 79106, Germany, <email>brigitte.strahm@uniklinik-freiburg.de</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Pediatric Hematology and Immunology, a section of the journal Frontiers in Pediatrics</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>7</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>3</volume><elocation-id>64</elocation-id><history><date date-type="received"><day>06</day><month>5</month><year>2015</year></date><date date-type="accepted"><day>25</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>Copyright © 2015 Erlacher and Strahm.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Erlacher and Strahm</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Peripheral blood cytopenia in children can be due to a variety of acquired or inherited diseases. Genetic disorders affecting a single hematopoietic lineage are frequently characterized by typical bone marrow findings, such as lack of progenitors or maturation arrest in congenital neutropenia or a lack of megakaryocytes in congenital amegakaryocytic thrombocytopenia, whereas antibody-mediated diseases such as autoimmune neutropenia are associated with a rather unremarkable bone marrow morphology. By contrast, pancytopenia is frequently associated with a hypocellular bone marrow, and the differential diagnosis includes acquired aplastic anemia, myelodysplastic syndrome, inherited bone marrow failure syndromes such as Fanconi anemia and dyskeratosis congenita, and a variety of immunological disorders including hemophagocytic lymphohistiocytosis. Thorough bone marrow analysis is of special importance for the diagnostic work-up of most patients. Cellularity, cellular composition, and dysplastic signs are the cornerstones of the differential diagnosis. Pancytopenia in the presence of a normo- or hypercellular marrow with dysplastic changes may indicate myelodysplastic syndrome. More challenging for the hematologist is the evaluation of the hypocellular bone marrow. Although aplastic anemia and hypocellular refractory cytopenia of childhood (RCC) can reliably be differentiated on a morphological level, the overlapping pathophysiology remains a significant challenge for the choice of the therapeutic strategy. Furthermore, inherited bone marrow failure syndromes are usually associated with the morphological picture of RCC, and the recognition of these entities is essential as they often present a multisystem disease requiring different diagnostic and therapeutic approaches. This paper gives an overview over the different disease entities presenting with (pan)cytopenia, their pathophysiology, characteristic bone marrow findings, and therapeutic approaches.</p></abstract><kwd-group><kwd>cytopenia</kwd><kwd>childhood</kwd><kwd>bone marrow failure</kwd><kwd>hypocellular bone marrow</kwd><kwd>myelodysplastic syndrome</kwd><kwd>refractory cytopenia of childhood</kwd><kwd>severe aplastic anemia</kwd></kwd-group><counts><fig-count count="1"></fig-count><table-count count="4"></table-count><equation-count count="0"></equation-count><ref-count count="158"></ref-count><page-count count="14"></page-count><word-count count="11973"></word-count></counts></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>(Pan)cytopenia in childhood can be caused by a variety of underlying diseases, including hematological and non-hematological entities. Overlapping phenotypes and pathophysiologies pose a major diagnostic challenge. However, an accurate and rapid diagnosis is essential for adequate therapy planning, surveillance, and genetic counseling. Bone marrow (BM) analysis is of special importance for the diagnostic work-up of cytopenias affecting one or more lineages. In the following, we will describe the individual disorders, their underlying pathophysiology and clinical characteristics, as well as typical BM findings.</p></sec><sec id="S2"><title>The Hierarchy of Hematopoiesis</title><p>All peripheral blood cells originate from hematopoietic stem cells (HSCs) that reside in fetal liver and fetal or adult BM. HSCs are able to self-renew, which is essential for maintenance of lifelong hematopoiesis. They do not commit directly to single lineages, but instead differentiate into multipotent progenitors, common lymphoid and (erythro-) myeloid progenitors, which in turn give rise to more differentiated precursor cells. Lineage commitment is determined by a delicate network of transcription factors and epigenetic mechanisms that establish differentiation into the corresponding lineage while suppressing maturation toward other lineages (<xref rid="B1" ref-type="bibr">1</xref>). The hierarchical tree of hematopoiesis is depicted in Figure <xref ref-type="fig" rid="F1">1</xref>, but there is evidence that such a linear and rigid model is oversimplified (<xref rid="B2" ref-type="bibr">2</xref>). Also, a specific HSC subset has been reported to directly evolve into megakaryocytes, at least in the murine system (<xref rid="B3" ref-type="bibr">3</xref>). Depending on the differentiation stage affected, disturbances can occur in single or multiple lineages (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Hierarchical tree of human hematopoiesis</bold>. Disturbances leading to cytopenias can affect single or multiple lineages and be caused by cell-intrinsic or extrinsic mechanisms. Intrinsic defects are caused by inherited or acquired mutations, while extrinsic defects can be caused by autoreactive lymphocytes. A selection of frequent pediatric disorders is shown. Labeling: inherited defects: red; acquired mutations: green; autoimmune disorders: blue. AIHA, autoimmune hemolytic anemia; ITP, idiopathic thrombocytopenic purpura.</p></caption><graphic xlink:href="fped-03-00064-g001"></graphic></fig></sec><sec id="S3"><title>Signs and Symptoms of Cytopenia</title><p>The condition caused by low erythrocyte numbers and hemoglobin concentration is called anemia and is clinically characterized by paleness, weakness, and general malaise. Severe anemia due to rapid hemoglobin drop (i.e., blood loss, hemolysis) may lead to cardiovascular symptoms such as tachycardia and arterial hypotension. Anemia due to bone marrow failure usually has insidious manifestation. Reticulocytosis points toward active red cell production while lack of reticulocytes is indicative for insufficient erythropoiesis. Other informative parameters are mean corpuscular volume (MCV) and HbF levels as signs of stress hematopoiesis or low haptoglobin with increased unconjugated bilirubin in the presence or absence of a positive antiglobulin test indicating hemolysis (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>Platelets are fragments of membrane and cytoplasm derived from megakaryocytes and important for hemostasis. Thrombocytopenia is characterized by cutaneous and mucosal bleeding signs, such as epistaxis, petechia, and purpura. Platelet size and morphology can help classifying the underlying disease. Platelets are abnormally small in patients with Wiskott–Aldrich syndrome (WAS) and large in patients with Bernard–Soulier syndrome or May–Hegglin anomaly (<xref rid="B5" ref-type="bibr">5</xref>). Platelet size diminishes over time, and therefore higher platelet volume may indicate the presence of less mature platelets in cases of increased degradation (e.g., idiopathic thrombocytopenic purpura, ITP) (<xref rid="B6" ref-type="bibr">6</xref>).</p><p>Lack of neutrophils, neutropenia, is characterized by an increased susceptibility to bacterial infections. Risk of infections correlates with granulocyte counts, with severe neutropenia (<500/μl) being associated with a high risk of life-threatening infections (<xref rid="B7" ref-type="bibr">7</xref>). Depending on the extent of neutropenia and the frequency of severe infections, prophylactic antibiotic treatment and/or G-CSF application might be considered. Response to G-CSF is indicative for the myelopoietic capacity of the BM.</p><p>In line with the many different types and developmental stages of lymphocytes, lymphopenia can affect an entire lineage (i.e., B, T, and/or NK cells) or individual mature cell types (e.g., regulatory T cells). Type of lacking cells as well as abundance of other lymphocyte types determine the phenotype of the individual disease. Phenotypes can be highly variable and range from (severe) combined immunodeficiency to mildly increased susceptibility to specific infections. Primary immune diseases can also be associated with immune dysregulation (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Neonatal cytopenias are particularly challenging due to the extremely diverse spectrum of differential diagnoses. Impairment of fetal erythropoiesis or thrombopoiesis due to inherited defects or prenatal infections can result in hydrops fetalis or perinatal hemorrhagic complications, respectively. Ineffective fetal hematopoiesis within the BM can lead to persistent extramedullary hematopoiesis in liver, spleen, and occasionally in the skin (<xref rid="B9" ref-type="bibr">9</xref>). Affected newborns are characterized by hepatosplenomegaly and may have skin infiltrations (so called “blueberry muffin” babies). The latter condition is indicative for hemolytic diseases, malignant BM infiltrations, infantile malignant osteopetrosis, or congenital infections (<xref rid="B10" ref-type="bibr">10</xref>). Neonatal erythroderma might indicate the presence of severe immune dysregulation as seen in Omenn’s syndrome, a hyperinflammatory variant of leaky SCID (<xref rid="B11" ref-type="bibr">11</xref>).</p><p>A detailed medical history is essential in all cases of cytopenias and should include details of concomitant health problems, susceptibility to bleeding or infections, previous exposure to drugs or toxins, and recent foreign travel. Family history should focus on hematological and immune disorders, cancer susceptibility, or unexplained infant deaths. Thorough physical examination should include the assessment of signs of lymphoproliferation (i.e., hepatosplenomegaly and lymphadenopathy), as well as dysmorphic features, and stigmata, indicating the presence of a syndromic disease.</p></sec><sec id="S4"><title>Cytopenia Affecting a Single Lineage</title><p>In principle, single lineage-cytopenias may be caused by insufficient production or premature depletion of mature cells of the respective hematopoietic lineage. In the majority of cases, the latter is mediated by autoreactive antibodies, resulting in ITP, autoimmune neutropenia (AIN), or autoimmune hemolytic anemia (AIHA), respectively (<xref rid="B12" ref-type="bibr">12</xref>). Frequently, autoantibodies are formed as a reaction to infections or vaccinations due to the so-called “molecular mimicry” between pathogen components and blood cell antigens (<xref rid="B13" ref-type="bibr">13</xref>). Similarly, heparin-induced thrombocytopenia (HIT) is caused by antibodies specific for heparin-binding platelets (<xref rid="B14" ref-type="bibr">14</xref>). Generally, these disorders show normal BM morphology or hyperactive hematopoiesis in the corresponding lineage. Most tests for autoantibodies have a low sensitivity and specificity, and are therefore not required for the confirmation of the diagnosis, except for AIHA (<xref rid="B15" ref-type="bibr">15</xref>). Since the BM is normal in ITP or AIN and thus has the capacity of increased cell production if stressed, signs and symptoms are frequently milder compared to patients with hypoproliferative deficiencies of these cell lineages. Even in the complete absence of peripheral granulocytes, patients rarely suffer from life-threatening infections. In contrast to these clinically mostly benign autoimmune disorders, AIHA, especially in childhood, can be life-threatening because of rapid hemoglobin decline (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>Furthermore, a premature destruction of red blood cells may be caused by defective hemoglobin, metabolic enzymes, or membrane components. These syndromes can be diagnosed by hemoglobin electrophoresis, determination of enzymatic activity or osmotic fragility tests, respectively, and will not be discussed here in more detail. Increased destruction of platelets and the subsequent risk of bleeding are also characteristic features of inherited disorders, such as Wiskott–Aldrich syndrome (WAS) and X-linked thrombocytopenia (XLT). While platelet generation has been shown to be unaffected in this syndrome, cytoskeletal changes occurring in circulating platelets lead to their premature degradation (<xref rid="B17" ref-type="bibr">17</xref>).</p><p>Similar to the single lineage-cytopenias caused by premature cell loss, disorders with inadequate cell generation can affect all individual lineages, i.e., megakaryopoiesis, erythropoiesis, and myelopoiesis. These disorders, their pathophysiologies, diagnostic characteristics, and symptoms are summarized in Table <xref ref-type="table" rid="T1">1</xref>. Disorders with insufficient generation of lymphocytes result in (severe) combined or milder immunodeficiencies. Since they require distinct diagnostic approaches and therapies, these syndromes are beyond the scope of this review and were discussed elsewhere (<xref rid="B18" ref-type="bibr">18</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Syndromes characterized by inadequate formation of mature blood cells resulting in single lineage cytopenia</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Disease/syndrome</th><th align="center" valign="top" rowspan="1" colspan="1">Mutated gene</th><th align="center" valign="top" rowspan="1" colspan="1">Pathogenesis</th><th align="center" valign="top" rowspan="1" colspan="1">Extrahematological features</th><th align="center" valign="top" rowspan="1" colspan="1">Hematopoietic phenotype</th><th align="center" valign="top" rowspan="1" colspan="1">Bone marrow morphology</th><th align="center" valign="top" rowspan="1" colspan="1">Therapeutic options</th><th align="center" valign="top" rowspan="1" colspan="1">Reference</th></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Severe congenital neutropenia (SCN)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>ELANE</italic>, <italic>HAX1</italic>, <italic>GFI1, G6PC3, p14</italic>, and others</td><td align="left" valign="top" rowspan="1" colspan="1">Differentiation block, myelocyte apoptosis</td><td align="left" valign="top" rowspan="1" colspan="1">Depending on disease (G6PC3: heart/uro-genital/facial anomalies)</td><td align="left" valign="top" rowspan="1" colspan="1">Severe neutropenia, risk of leukemia</td><td align="left" valign="top" rowspan="1" colspan="1">Maturation arrest at promyelocyte stage</td><td align="left" valign="top" rowspan="1" colspan="1">G-CSF, antibiotic prophylaxis, HSCT, leukemia surveillance</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B19" ref-type="bibr">19</xref>–<xref rid="B21" ref-type="bibr">21</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Cyclic neutropenia</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>ELANE</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Cyclic increase in myelocyte apoptosis</td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclic neutropenia, normal blood in intervals</td><td align="left" valign="top" rowspan="1" colspan="1">Intermittendly similarities to SCN</td><td align="left" valign="top" rowspan="1" colspan="1">G-CSF</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B22" ref-type="bibr">22</xref>)</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Glycogen storage disease type 1b</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Glucose-6-phosphate translocase</td><td align="left" valign="top" rowspan="1" colspan="1">Impaired glucose formation from glycogen</td><td align="left" valign="top" rowspan="1" colspan="1">Hypoglycemia, increased hepatic and renal glycogen storage</td><td align="left" valign="top" rowspan="1" colspan="1">Neutropenia, granulocyte dysfunction</td><td align="left" valign="top" rowspan="1" colspan="1">Normal</td><td align="left" valign="top" rowspan="1" colspan="1">G-CSF</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B23" ref-type="bibr">23</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Shwachman Diamond syndrome (SDS)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>SBDS</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Ribosome assembly and function and many other cellular functions</td><td align="left" valign="top" rowspan="1" colspan="1">Exocrine pancreatic insufficiency, skeletal abnormalities, growth retardation</td><td align="left" valign="top" rowspan="1" colspan="1">Neutropenia, pancytopenia (25%), risk of leukemia</td><td align="left" valign="top" rowspan="1" colspan="1">Maturation arrest of myelopoiesis, hypocellular bone marrow</td><td align="left" valign="top" rowspan="1" colspan="1">G-CSF, HSCT</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B24" ref-type="bibr">24</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Congenital dyserythropoietic anemia (CDA)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>CDAN1</italic>, <italic>SEC23B</italic>, <italic>KIF23</italic>, <italic>KLF1</italic>, and others</td><td align="left" valign="top" rowspan="1" colspan="1">Ineffective erythropoiesis</td><td align="left" valign="top" rowspan="1" colspan="1">Iron overload</td><td align="left" valign="top" rowspan="1" colspan="1">Anemia</td><td align="left" valign="top" rowspan="1" colspan="1">Dyserythropoetic maturation of erythroblast</td><td align="left" valign="top" rowspan="1" colspan="1">RBC transfusions, chelation therapy</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B25" ref-type="bibr">25</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Diamond-Blackfan anemia (DBA)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Ribosomal genes (<italic>RPS19, RPL5, RPL11, RPL35A</italic>, and others)</td><td align="left" valign="top" rowspan="1" colspan="1">Ribosomopathy</td><td align="left" valign="top" rowspan="1" colspan="1">Thumb malformations and craniofacial abnormalities</td><td align="left" valign="top" rowspan="1" colspan="1">Macrocytic anemia, variable neutrophils, and platelet numbers, risk of leukemia</td><td align="left" valign="top" rowspan="1" colspan="1">Paucity of erythroid precursors</td><td align="left" valign="top" rowspan="1" colspan="1">Steroids, RBC transfusions, chelation therapy, HSCT</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B26" ref-type="bibr">26</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Thalassaemia major</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Globin genes (<italic>HBA1</italic>, <italic>HBA2</italic>, <italic>HBB</italic>)</td><td align="left" valign="top" rowspan="1" colspan="1">Unbalanced synthesis of globins</td><td align="left" valign="top" rowspan="1" colspan="1">Bone deformities, iron overload</td><td align="left" valign="top" rowspan="1" colspan="1">Anemia due to ineffective hematopoiesis and hemolysis, extramedullar hematopoiesis</td><td align="left" valign="top" rowspan="1" colspan="1">Hyperplastic erythropoiesis, apoptosis of erythroid precursors</td><td align="left" valign="top" rowspan="1" colspan="1">RBC transfusions, chelation therapy, HSCT</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">27</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Pure red cell aplasia (PRCA)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Unknown</td><td align="left" valign="top" rowspan="1" colspan="1">Unknown (autoimmune?)</td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Anemia</td><td align="left" valign="top" rowspan="1" colspan="1">Absence of erythroblasts (maturation arrest)</td><td align="left" valign="top" rowspan="1" colspan="1">Transfusions, immunosuppression</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B28" ref-type="bibr">28</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Anemia of renal failure</bold></td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Insufficient erythropoietin production</td><td align="left" valign="top" rowspan="1" colspan="1">Depending on underlying disease</td><td align="left" valign="top" rowspan="1" colspan="1">Normocytic anemia</td><td align="left" valign="top" rowspan="1" colspan="1">Uncharacteristic findings</td><td align="left" valign="top" rowspan="1" colspan="1">Erythropoietin substitution</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B29" ref-type="bibr">29</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Anemia of chronic inflammation</bold></td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Hyperinflammation, hepcidin deregulation</td><td align="left" valign="top" rowspan="1" colspan="1">Depending on underlying disease</td><td align="left" valign="top" rowspan="1" colspan="1">Normo- to microcytic anemia</td><td align="left" valign="top" rowspan="1" colspan="1">Uncharacteristic findings</td><td align="left" valign="top" rowspan="1" colspan="1">Treatment of underlying disease</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Congenital amegakaryocytic thrombocytopenia (CAMT)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>MPL</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Megakaryopoiesis unresponsive to thrombopoietin</td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Thrombocytopenia, pancytopenia, risk of leukemia</td><td align="left" valign="top" rowspan="1" colspan="1">Near-absence of megakaryocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Transfusions, HSCT</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B31" ref-type="bibr">31</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Thrombocytopenia with absent radius (TAR)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Chr. 1q21.1 deletion (<italic>RBM8A?</italic>)</td><td align="left" valign="top" rowspan="1" colspan="1">Insufficient megakaryopoiesis (unknown cause)</td><td align="left" valign="top" rowspan="1" colspan="1">Absence of radius (thumb present), cardiovascular and gastrointestinal malformations</td><td align="left" valign="top" rowspan="1" colspan="1">Thrombocytopenia, risk of leukemia</td><td align="left" valign="top" rowspan="1" colspan="1">Decreased or absent, small megakaryocytes with vacuolization</td><td align="left" valign="top" rowspan="1" colspan="1">Transfusions, HSCT</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B32" ref-type="bibr">32</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Familial platelet disorder (FPD)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Runx1</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Defective expression of RUNX1 targets (e.g., <italic>MPL</italic>)</td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Mild thrombocytopenia, high risk of MDS/leukemia</td><td align="left" valign="top" rowspan="1" colspan="1">Normal or dysplastic signs</td><td align="left" valign="top" rowspan="1" colspan="1">Transfusions, HSCT, leukemia surveillance</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B33" ref-type="bibr">33</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Bernhard–Soulier syndrome</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>GP1BA</italic>, <italic>GP1BB</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Defective platelet formation, reduced platelet lifespan</td><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">Thrombocytopenia, increased platelet size</td><td align="left" valign="top" rowspan="1" colspan="1">Increased megakaryopoiesis</td><td align="left" valign="top" rowspan="1" colspan="1">Transfusions</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B34" ref-type="bibr">34</xref>)</td></tr><tr><td colspan="8" rowspan="1"><hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>May–Hegglin anomaly</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>MYH9</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Defective megakaryocyte maturation</td><td align="left" valign="top" rowspan="1" colspan="1">Sensineural deafness, cataract, nephritis</td><td align="left" valign="top" rowspan="1" colspan="1">Mild thrombocytopenia, increased platelet size</td><td align="left" valign="top" rowspan="1" colspan="1">Inclusion bodies in neutrophils</td><td align="left" valign="top" rowspan="1" colspan="1">Symptomatic treatment</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B5" ref-type="bibr">5</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic>ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; G-CSF, granulocyte colony-stimulating factor; HSCT, hematopoietic stem cell transplantation; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasia; RBC, red blood cells</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="S5"><title>When More Lineages are Affected</title><p>Cytopenias affecting two or three blood lineages, the latter called pancytopenia (greek <inline-formula><mml:math id="M1"><mml:mrow><mml:mn>π</mml:mn><mml:mover accent="true"><mml:mn>α</mml:mn><mml:mrow><mml:mn>˜</mml:mn></mml:mrow></mml:mover><mml:mn>ν</mml:mn></mml:mrow></mml:math></inline-formula>, <italic>pan</italic> = involving all), can also be caused by deregulation of either cell generation or degradation. As an additional layer of classification, the disorders can be divided into inherited or acquired BM failures. It is important to emphasize that inherited BM failure syndromes (IBMFS) as well as acquired BM failure can present in all age groups, and that in some cases an isolated cytopenia preceeds the development of pancytopenia. This requires particular attention and repeated reevaluation by the attending physician or hematologist. Isolated thrombocytopenia can initially be diagnosed as ITP, but additional anemia or neutropenia over time might indicate the presence of systemic autoimmune disorders such as systemic lupus erythematosus (SLE). Similarly, isolated neutropenia can be considered to be secondary to an infection, but the subsequent decrease of other blood cells should rapidly lead to BM analysis. In the following, we will describe the different forms of pancytopenia in more detail.</p></sec><sec id="S6"><title>Pancytopenia as Consequence of Autoimmunity and Immune Dysregulation</title><p>While single-line immune-mediated degradation of platelets, erythrocytes, or neutrophils is frequent, combinations thereof are rare and often serious (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). The combination of AIHA and thrombocytopenia, occurring either simultaneously or sequentially, is called Evans syndrome and is often a manifestation of the autoimmune lymphoproliferative syndrome (ALPS) (<xref rid="B37" ref-type="bibr">37</xref>). ALPS is caused by germline or somatic mutations in <italic>FAS</italic>, <italic>FASL</italic>, or <italic>CASP10</italic>, resulting in insufficient apoptosis of activated autoreactive lymphocytes via the extrinsic pathway (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Rarely, ALPS can be caused by <italic>RAS</italic> mutations resulting in defective intrinsic apoptosis of lymphocytes (<xref rid="B40" ref-type="bibr">40</xref>). Concomitant lymphoproliferation is characteristic for ALPS. Similarly, cytopenias can occur in acquired, multifactorial autoimmune syndromes such as SLE or the primary antiphospholipid syndrome (<xref rid="B36" ref-type="bibr">36</xref>). Germline syndromes characterized by autoimmunity are the IPEX (immunodysregulation polyendocrinopathy enteropathy X-linked) syndrome caused by lack of regulatory T cells and the APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy) syndrome caused by insufficient induction of central (thymic) tolerance (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). Other primary immunodeficiencies frequently leading to autoimmune cytopenia are leaky SCID, WAS, hyper-IgM syndrome, and common variable immunodeficiency (CVID) (<xref rid="B36" ref-type="bibr">36</xref>). Indicative of the presence of such syndromes are lymphoproliferation, autoantibodies, oligoclonal T cells, increased complement consumption, and signs of autoimmunity or autoinflammation affecting other organs (i.e., dermatitis, glomerulonephritis, and inflammatory bowel disease). Bone marrow findings are usually not characteristic and merely indicate increased cellular turnover.</p><p>Immune dysregulation is also the cause of pancytopenia in patients with hemophagocytic lymphohistiocytosis (HLH). This life-threatening syndrome is characterized by impaired pathogen elimination, hyperinflammation, and hystiocytic and lymphoid tissue infiltration. It can occur as familial disease (FHL with <italic>PRF1</italic>, <italic>UNC13D</italic>, <italic>STX11</italic>, or <italic>STXBP2</italic> mutations), in syndromes characterized by additional albinism (i.e., Griscelli syndrome type II, Hermansky-Pudlak syndrome type II, and Chediak-Higashi syndrome) and secondary to infection, rheumatic, or neoplastic disorders. Secondary HLH is also known as macrophage activation syndrome (MAS). Deregulation of T and NK cell cytotoxicity and/or lysosomal trafficking are underlying mechanisms of HLH (<xref rid="B43" ref-type="bibr">43</xref>). Pancytopenia is not mediated by autoantibodies but instead by macrophage hyperactivation, resulting in hemophagocytosis and cytokine-mediated marrow suppression. Accordingly, hemophagocytosis in BM is one of the diagnostic criteria, next to hypertriglyceridemia, hypofibrinogenemia, and increased levels of ferritin and soluble IL2 receptor. Degranulation and cytotoxicity assays as well as genetic analysis confirm the diagnosis (<xref rid="B44" ref-type="bibr">44</xref>).</p></sec><sec id="S7"><title>Extrinsic Conditions Associated with Impaired Hematopoiesis</title><p>Certain extrinsic, environmental conditions can interfere significantly with blood formation, either pre- or postnatally. The most frequent causes of impaired hematopoiesis are infections. Congenital TORCH infections (i.e., toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and others) often result in decreased maturation of megakaryocytes and platelet formation, in combination with increased immune-mediated platelet destruction (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Parvovirus B19 infections lead to apoptosis and cell cycle arrest in infected fetal erythroblasts, thereby resulting in fetal anemia and hydrops (<xref rid="B47" ref-type="bibr">47</xref>). Also postnatally, parvovirus B19 can transiently affect erythroid progenitors. While healthy children are only mildly affected, children with hemolytic anemia and immunocompromised patients might develop aplastic crisis and persistent anemia, respectively (<xref rid="B48" ref-type="bibr">48</xref>). Many other viral infections are associated with transient hematopoietic depression of one or more lineages. Important infections to be considered in the differential diagnosis of peripheral cytopenias are hepatitis C, HIV (in children nowadays mostly due to vertical transmission), and <italic>Helicobacter pylori</italic>, all causing thrombocytopenia and some of them anemia. Visceral leishmaniasis, in contrast, results in an HLH-like disorder with massive phagocytosis of blood components (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>).</p><p>Other causes of suppressed hematopoiesis are nutritional deficiencies observed in anorexia nervosa or B12, folate, and iron deficiency. While mild deficiencies frequently cause anemia, severe lack of essential food components can result in complete BM failure and immunodeficiency (<xref rid="B51" ref-type="bibr">51</xref>–<xref rid="B53" ref-type="bibr">53</xref>).</p><p>Finally, hematopoiesis can be restricted by pathological microenvironmental conditions. In Gaucher disease, BM dysfunction is caused by accumulation of glucocerebrosides in macrophages and results in (pan)cytopenia (<xref rid="B54" ref-type="bibr">54</xref>). By contrast, osteopetrosis is caused by reduced bone resorption leading to bone sclerosis and, among other symptoms, restriction of the medullar cavity. This results in BM failure and compensatory extramedullary hematopoiesis. Different disease subtypes have been reported, with infantile malignant osteopetrosis being the most severe form (<xref rid="B55" ref-type="bibr">55</xref>).</p></sec><sec id="S8"><title>Inherited Intrinsic Defects of Hematopoiesis</title><p>Various inborn genetic defects result in hematopoietic failure, and most of them are not restricted to hematopoiesis but also affect different organ systems. Traditionally, Fanconi anemia (FA), dyskeratosis congenita (DC), congenital amegakaryocytic thrombocytopenia (CAMT), thrombocytopenia with absent radii (TAR), Diamond Blackfan anemia (DBA), Shwachman Diamond syndrome (SDS), and severe congenital neutropenia (SCN) have been subsumed as inherited BM failure syndromes (IBMFS). BM failure can occur at different ages and has highly variable presentations. Disease kinetics and degree of severity depend on the underlying gene mutation and presumably on concomitant polymorphisms and environmental influences, such as life style, infections, and exposition to toxins (<xref rid="B56" ref-type="bibr">56</xref>). Underlying pathogenetic mechanisms are heterogeneous and comprise metabolic dysfunction, inhibition of differentiation, ribosomal dysfunction, DNA repair deficiency, and telomere maintenance.</p><p>In DBA, SDS, SCN, CAMT, and TAR, primarily one hematopoietic lineage is affected. These syndromes, their underlying pathogenesis, and phenotype, as well as characteristic BM findings are summarized in Table <xref ref-type="table" rid="T1">1</xref>. However, it has to be kept in mind that patients with CAMT or SDS frequently show a progress from isolated thrombocytopenia or neutropenia, respectively, to complete BM failure (<xref rid="B31" ref-type="bibr">31</xref>). In DBA, erythropoiesis is primarily affected but full BM failure also occurs at low frequency (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B56" ref-type="bibr">56</xref>). Ribosomal dysfunction has been shown to induce excessive TP53 activation leading to apoptosis and being most harmful to highly proliferating erythroid progenitor cells (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B26" ref-type="bibr">26</xref>).</p><p>In the following, we will focus on syndromes affecting more than one hematopoietic lineage and frequently resulting in severe BM failure and pancytopenia. One of the most severe forms of hematopoietic failure is reticular dysgenesis, a rare, autosomal-recessive syndrome. Erythro- and megakaryopoiesis have been described to be unaffected in some patients, but newborns present with complete absence of neutrophils and early onset SCID. Due to the lack of both innate and adaptive immune functions, reticular dysgenesis is rapidly fatal unless hematopoietic stem cell transplantation (HSCT) is performed. Mutations in the <italic>AK2</italic> gene have been identified to be causative for some cases, but most remain unsolved (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>).</p><p>The most frequent syndromes characterized by severe BM failure are FA and DC. In FA, mutations are found in 15 different genes (<italic>FANCA</italic>, <italic>FANCC</italic>, <italic>FANCG</italic>, <italic>FANCD2</italic>, and others), all involved in DNA damage repair, particularly in resolution of DNA interstrand cross-links during replication. Patients may present with congenital abnormalities, such as short stature, microphthalmia, thumb and radius deformities, café-au-lait spots and heart, renal and genitourinary malformations. Hematopoietic failure often emerges in childhood or adolescence, and most patients are only diagnosed with FA at the onset of pancytopenia (<xref rid="B59" ref-type="bibr">59</xref>). When treated with mitomycin C, FA cells accumulate chromosomal breaks and undergo G2 arrest, which is used as a diagnostic test (<xref rid="B60" ref-type="bibr">60</xref>). DC is a disease caused by mutations in genes affecting telomere elongation and maintenance (<italic>DKC1</italic>, <italic>TERC</italic>, <italic>TERT, TINF2</italic>, and others). Although the disease was first characterized by its mucocutaneous symptoms (i.e., skin pigmentation, nail dystrophy, and mucosal leukoplakia), it is now known that the development of BM failure may preceed the mucocutaneous manifestations. Age of onset and disease phenotype are highly variable and at least partially depend on characteristic mutations (<xref rid="B61" ref-type="bibr">61</xref>). By contrast, the diagnostic work-up invariably reveals very short telomeres at time of presentation. Unresolved DNA damage and critically short telomeres induce DNA damage checkpoint activation in FA and DC cells, respectively, with TP53 being a critical mediator (<xref rid="B62" ref-type="bibr">62</xref>). As a consequence, cells stop proliferation, and senescence or apoptosis are induced. Together, these pathways confer protection from malignant transformation but at the same time they contribute to BM failure and pancytopenia. As a consequence, FA and DC cells have a high selective pressure to inactivate the DNA damage checkpoint, as reflected by their high propensity to develop secondary MDS and AML (Tables <xref ref-type="table" rid="T2">2</xref> and <xref ref-type="table" rid="T3">3</xref>) (<xref rid="B63" ref-type="bibr">63</xref>). The highest risk is observed in FA patients where accumulation of DNA damage and unresolved chromosomal aberrations rapidly lead to malignant transformation (<xref rid="B64" ref-type="bibr">64</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><bold>Susceptibility to malignancies in inherited bone marrow failure syndromes (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B65" ref-type="bibr">65</xref>–<xref rid="B71" ref-type="bibr">71</xref>)</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Inherited bone marrow failure syndrome</th><th align="left" valign="top" rowspan="1" colspan="1">Reported malignancies</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Fanconi anemia (FA)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes, acute myeloid and lymphatic leukemia, head and neck squamous cell carcinoma, vulva, esophageal, breast and skin carcinoma, brain tumors, basal cell carcinoma</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Dyskeratosis congenita (DC)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes, acute myeloid leukemia, non-Hodgkin lymphoma, head and neck squamous cell carcinoma, cervix carcinoma, basal cell carcinoma</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Diamond-Blackfan anemia (DBA)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes, acute myeloid leukemia, colon and lung carcinoma, basal cell carcinoma, osteogenic sarcoma, female genital cancers</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Shwachman-Diamond syndrome (SDS)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes, acute myeloid leukemia, pancreatic ductal adenocarcinoma (<italic>n</italic> = 1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Cartilage-hair hypoplasia (CHH)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphatic leukemia, squamous cell carcinoma, basal cell carcinoma</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Thrombocytopenia absent radius syndrome (TAR)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Acute myeloid leukemia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Congenital amegakaryocytic thrombocytopenia (CAMT)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Acute myeloid leukemia, acute lymphoblastic leukemia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Severe congenital neutropenia (SCN)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes, acute myeloid leukemia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Familial platelet disorder (FPD)</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes, acute myeloid leukemia, myeloproliferative neoplasms, acute T lymphoblastic leukemia</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><bold>The different pathophysiological mechanisms and their relative contributions to inherited bone marrow failure syndromes, severe aplastic anemia, and myelodysplastic syndromes</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Pathophysiological mechanism</th><th align="center" valign="top" rowspan="1" colspan="1">Inherited bone marrow failure syndromes (IBMFS)</th><th align="left" valign="top" rowspan="1" colspan="1">Myelodysplastic syndromes (MDS)</th><th align="left" valign="top" rowspan="1" colspan="1">Severe aplastic anemia (SAA)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Inherited cell-intrinsic defects</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p><bold>Causative for all forms of ÍBMFS</bold></p></list-item><list-item><label>–</label><p>TP53 activation in FA, DC, and DBA cells results in cell cycle inhibition, senescence, and apoptosis meant to protect from malignant transformation but at the same time contributing to BM failure and pancytopenia (<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Familial cases are caused by <italic>RUNX1</italic> or <italic>GATA2</italic> mutations leading to deregulation of the stem and progenitor cell function (<xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>)</p></list-item><list-item><label>–</label><p>No inherited mutations are known for sporadic cases</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>No evidence</p></list-item></list></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Acquisition of driver mutations</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Secondary evolution to MDS and/or AML (<xref rid="B65" ref-type="bibr">65</xref>)</p></list-item><list-item><label>–</label><p>Transformation driven by cumulative injury of proliferating cell (e.g., accumulation of DNA damage or chromosomal instability) (<xref rid="B64" ref-type="bibr">64</xref>)</p></list-item><list-item><label>–</label><p>Compensatory proliferation and selective pressure in pancytopenic patients contribute to transformation (<xref rid="B64" ref-type="bibr">64</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p><bold>Driving force for MDS development and evolution to AML</bold></p></list-item><list-item><label>–</label><p>Typical driver mutations conferring clonal advantages affect the <italic>ASXL1</italic>, <italic>EXH2</italic>, <italic>IDH1</italic>, <italic>IDH2</italic>, <italic>KRAS</italic>, <italic>NRAS</italic>, and <italic>TET2</italic> genes (<xref rid="B76" ref-type="bibr">76</xref>)</p></list-item><list-item><label>–</label><p>Such mutations can result in clonal hematopoiesis even before overt MDS and AML occurs (<xref rid="B77" ref-type="bibr">77</xref>)</p></list-item><list-item><label>–</label><p>Also, familial MDS forms require second hits (e.g., monosomy 7 in patients with <italic>GATA2</italic> mutation or loss of heterozygosity in patients with <italic>RUNX1</italic> mutations) (<xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B79" ref-type="bibr">79</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Secondary evolution to MDS</p></list-item><list-item><label>–</label><p>Critical drivers of clonal evolution are compensatory proliferation in the hypocellular marrow and immune escape (<xref rid="B64" ref-type="bibr">64</xref>)</p></list-item><list-item><label>–</label><p>Characteristic clonal findings: PNH clones with <italic>PIGA</italic> mutations, deletion of (antigenic) HLA alleles by loss of the chromosomal arm 6p or typical MDS mutations (<italic>ASXL1</italic>, <italic>DNMT3A</italic>, <italic>TET2</italic>, and others) (<xref rid="B80" ref-type="bibr">80</xref>–<xref rid="B82" ref-type="bibr">82</xref>)</p></list-item></list></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Autoimmunity</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>No contribution reported (<xref rid="B83" ref-type="bibr">83</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Clonal T cells were found in MDS patients. Conflicting results indicate that they are either derived from the MDS clone or have been induced by antigenic mutations in MDS cells (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>)</p></list-item><list-item><label>–</label><p>Approximately 10% of MDS patients have autoimmune-inflammatory manifestations, but the pathophysiological relationship between MDS and autoimmunity remains unclear (<xref rid="B86" ref-type="bibr">86</xref>)</p></list-item><list-item><label>–</label><p>Some patients show hematological recovery upon immunosuppressive therapy (<xref rid="B87" ref-type="bibr">87</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p><bold>Primary event for SAA</bold></p></list-item><list-item><label>–</label><p>Mediated mainly by CD8+ cytotoxic T and Th1 cells that are recruited to the BM (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>)</p></list-item><list-item><label>–</label><p>Association with certain HLA alleles (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>)</p></list-item><list-item><label>–</label><p>Autoantibodies have been identified but their significance remains unclear (<xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>)</p></list-item><list-item><label>–</label><p>Patients show a good response to immunosuppressive therapy (<xref rid="B94" ref-type="bibr">94</xref>, <xref rid="B95" ref-type="bibr">95</xref>)</p></list-item></list></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Inflammatory signaling</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Inflammation and infectious diseases are thought to accelerate BM failure. Repeated interferon stimulation induces BM failure in a Fanconi mouse model (<xref rid="B96" ref-type="bibr">96</xref>)</p></list-item><list-item><label>–</label><p>Cytokines induce proliferation and subsequent exhaustion of stem cells. Cycling stem cells get more susceptible toward apoptosis (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Overproduction of cytokines (i.e., TNFα and IFNγ) by the stem cell niche contributes to apoptosis of MDS cells (<xref rid="B98" ref-type="bibr">98</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Th1-shifted cytokine secretion with (i.e., IFNγ, TNFα, and IL-2) contributes to disease pathogenesis by suppressing hematopoiesis (<xref rid="B99" ref-type="bibr">99</xref>–<xref rid="B101" ref-type="bibr">101</xref>)</p></list-item></list></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Deregulation of the stem cell niche</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>There is evidence that the function of the stem cell niche is compromised because of the underlying genetic mutation (<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B103" ref-type="bibr">103</xref>)</p></list-item><list-item><label>–</label><p>However, allogeneic stem cell transplantation can correct all hematological symptoms indicating a minor contribution to disease by the microenvironment</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>Microenvironmental deregulation contributes to pathogenesis (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B104" ref-type="bibr">104</xref>)</p></list-item><list-item><label>–</label><p>In animal models, niche alterations can be sufficient to induce MDS (i.e., by Dicer mutations) (<xref rid="B105" ref-type="bibr">105</xref>)</p></list-item><list-item><label>–</label><p>Clonal hematopoiesis remodels the niche: in MDS xenograft models, healthy mesenchymal stromal cells cotransplanted with MDS cells adopt molecular features observed in mesenchymal stromal cells derived from MDS patients (<xref rid="B106" ref-type="bibr">106</xref>)</p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><label>–</label><p>There is evidence that the stem cell niche might contribute to T cell activation; the results however are conflicting (<xref rid="B88" ref-type="bibr">88</xref>)</p></list-item></list></td></tr></tbody></table><table-wrap-foot><p><italic>AML, acute myeloid leukemia; BM, bone marrow; DBA, Diamond Blackfan anemia; DC, dyskeratosis congenita; FA, Fanconi anemia; PNH, paroxysmal nocturnal hemoglobinuria; SDS, Shwachman Diamond syndrome</italic>.</p></table-wrap-foot></table-wrap><p>Other genetic diseases associated with pancytopenia are Seckel and Pearson syndromes. Seckel syndrome represents a DNA damage repair deficiency characterized by BM failure, dwarfism, microcephaly, mental retardation, and skeletal malformations. Among others, <italic>ATR</italic> mutations have been identified to be responsible for this rare syndrome (<xref rid="B107" ref-type="bibr">107</xref>). Pearson syndrome is caused by loss of mitochondrial DNA and thus one of the so called mitochondriopathies. Next to failure to thrive, exocrine pancreatic dysfunction, and susceptibility to metabolic imbalance, patients frequently suffer from anemia, thrombocytopenia, and/or neutropenia. BM analysis typically shows sideroblastic anemia and vacuolization of hematopoietic precursor cells (<xref rid="B108" ref-type="bibr">108</xref>).</p><p>It is hardly surprising that DNA damage deficiencies, telomeropathies, ribosomopathies, or mitochondriopathies do not only disturb hematopoiesis but also affect developmental programs and adult tissues. Many of the syndromes described here are additionally characterized by an increased susceptibility to malignancies, including hematological malignancies and solid tumors (Table <xref ref-type="table" rid="T2">2</xref>) (<xref rid="B65" ref-type="bibr">65</xref>–<xref rid="B71" ref-type="bibr">71</xref>). It is obvious that both, the multisystemic nature of disease and the tumor susceptibility, have to be taken into account during patient care and therapy planning. It is therefore of great importance to recognize the underlying cause of BM failure even in patients with mild or no extrahematological symptoms (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B109" ref-type="bibr">109</xref>). Pitfalls and diagnostic approaches especially in disorders with hypocellular BM are discussed below.</p></sec><sec id="S9"><title>Acquired Disorders of Hematopoiesis</title><sec id="S9-1"><title>Myelodysplastic syndrome</title><p>Myelodysplastic syndrome (MDS) is a clonal disorder originating from a hematopoietic stem/progenitor cell that supposedly has acquired driver mutations. Due to deregulation of differentiation and increased susceptibility to apoptosis, MDS is characterized by ineffective hematopoiesis in one or more lineages. BM analysis shows characteristic dysplastic cells, such as micromegakaryocytes, binucleated erythroid precursors, and hypo- or hypersegmented neutrophils. MDS has a high propensity to further progress to more advanced disease, including MDS-related acute myeloid leukemia (MDR-AML). This evolution is caused by additional subclonal driver mutations that have been acquired in a stepwise manner and result in further increase in proliferation and impairment of differentiation (<xref rid="B110" ref-type="bibr">110</xref>).</p><p>In general, MDS is a disease of old age, with an incidence of 50 cases per 100,000 persons aged over 70 years. As shown recently, even healthy, aged individuals frequently have clonal expansion of hematopoietic cells harboring driver mutations (i.e., <italic>DNMT3A</italic>, <italic>JAK2</italic>, <italic>TET2</italic>, and others), although they do not (yet) suffer from overt MDS or leukemia (<xref rid="B77" ref-type="bibr">77</xref>). Risk of MDS is further increased in people exposed to chemo- or radiotherapy earlier in life with a life-time risk of 2–10% after treatment with alkylating agents, topoisomerase II inhibitors, or ionizing irradiation (<xref rid="B111" ref-type="bibr">111</xref>).</p><p>By contrast, childhood MDS is rare, and differs from adult MDS in several aspects. For this reason, the WHO 2008 classification incorporated a classification specific for childhood MDS allowing unambiguous classification of most patients (<xref rid="B112" ref-type="bibr">112</xref>). Depending on the number of blasts in peripheral blood (PB) and BM, childhood MDS is classified as refractory cytopenia of childhood (RCC; PB blasts <2%, BM blasts <5%), refractory anemia with excess blasts (RAEB; PB blasts 2–10%, and/or BM blasts 5–19%), RAEB in transformation (RAEB-T; PB and/or BM blasts 20–29%), and MDR-AML (>30% BM blasts) (<xref rid="B113" ref-type="bibr">113</xref>). The most common subtype is RCC (50%). While adult MDS patients usually present with isolated anemia (“refractory anemia”), affected children frequently present with thrombocytopenia (<150,000/μl; 75%), neutropenia (<1,000/μl; 50%), and/or anemia (Hb <10 g/dl; 50%). HbF and MCV are frequently elevated (<xref rid="B114" ref-type="bibr">114</xref>). In >80% of all RCC cases, BM analysis reveals a marked decrease of cellularity. The remaining 20% of patients with RCC have a normo- or hypercellular BM (<xref rid="B114" ref-type="bibr">114</xref>).</p><p>Common cytogenetic abnormalities of childhood MDS are monosomy 7 (approximately 30%) and trisomy 8. Loss of chromosome 5q, frequently seen in adults, is only rarely found in children. A structurally complex karyotype (≥3 chromosomal aberrations including at least one structural aberration) is rare but invariably associated with poor prognosis (<xref rid="B115" ref-type="bibr">115</xref>–<xref rid="B117" ref-type="bibr">117</xref>). Chromosomal aberrations do not represent initiating events but indicate disease progression. Along this line, karyotypic evolution is usually accompanied by progression to more advanced MDS forms. The incidence of cytogenetic abnormalities is lowest in RCC with hypocellular BM. Patients with RCC and monosomy 7 are at high risk of progression with a cumulative incidence of 80% at 6 years from diagnosis and a median time to progression of 1.9 years (<xref rid="B118" ref-type="bibr">118</xref>). By contrast, RCC patients with a normal karyotype or trisomy 8 may have stable disease for many years. Patients with advanced MDS are at risk for further disease progression and have an indication for early HSCT (<xref rid="B114" ref-type="bibr">114</xref>). In infants, monosomy 7 or del(7q) has also been reported to disappear spontaneously, however, only in rare cases (<xref rid="B119" ref-type="bibr">119</xref>).</p><p>Next to sporadic cases, MDS can arise secondary to inherited or acquired BM disorders or in the context of chemo/radiotherapy. Importantly, all IBMFS described above have a risk to transform into secondary MDS, as described above in more detail for FA and DC (Table <xref ref-type="table" rid="T2">2</xref>) (<xref rid="B64" ref-type="bibr">64</xref>). Lifetime risk of IBMFS patients is highly variable and ranges from very high in patients with FA (40–50% by the age of 40 years) to very low in DBA patients (<xref rid="B65" ref-type="bibr">65</xref>). Patients with other inherited syndromes might develop MDS directly without hypocellular prophase (<xref rid="B120" ref-type="bibr">120</xref>). <italic>GATA2</italic> haploinsufficiency is the most frequent reason for such familiar MDS. Patients show variable disease complexes with extrahematological symptoms, such as lymphedema and deafness, and 40% develop MDS during adolescence and early adulthood. Preceding hematological and immunological symptoms are heterogeneous and include monocytopenia, mild neutropenia, and DC, B and/or NK cell deficiency. Depending on the predominant symptoms, the syndrome was named DCML (dendritic cell, monocyte, B and NK lymphoid) deficiency, Emberger syndrome, or MonoMAC (<xref rid="B121" ref-type="bibr">121</xref>). Similarly, patients with heterozygous germline <italic>RUNX1</italic> mutation have a high propensity to develop MDS (20–50%). Since precedent hematological symptoms are limited to qualitative and quantitative platelet defects, the syndrome is called familial platelet disorder (FPD) (<xref rid="B33" ref-type="bibr">33</xref>). It is not yet fully understood, why patients with <italic>RUNX1</italic> and <italic>GATA2</italic> mutations are at such high risk for MDS (<xref rid="B120" ref-type="bibr">120</xref>).</p></sec><sec id="S9-2"><title>Severe aplastic anemia</title><p>While MDS is an intrinsic disorder of hematopoiesis, severe aplastic anemia (SAA) is an autoimmune process. In contrast to autoimmune cytopenias affecting mature blood cells, immature and multipotent cells are targeted in SAA resulting in the severe phenotype characterized by pancytopenia and BM aplasia (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B94" ref-type="bibr">94</xref>). Evidence for the immune pathophysiology of the disease was first derived from clinical observations such as the response to immunosuppressive therapy (IST) or successful autologous recovery after failed allogeneic HSCT (<xref rid="B122" ref-type="bibr">122</xref>, <xref rid="B123" ref-type="bibr">123</xref>). Since then, much effort has been invested in characterization of the immune phenotype, and certain HLA alleles have been associated with an increased risk (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). Autoantibodies against different antigens (e.g., antimoesin or kinectin) have been detected in SAA patients but their significance remains unknown (<xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>). Detailed analysis of the T cell compartment revealed a recruitment of activated T cells to the BM (<xref rid="B124" ref-type="bibr">124</xref>) and oligoclonality in some cases (<xref rid="B125" ref-type="bibr">125</xref>–<xref rid="B128" ref-type="bibr">128</xref>). CD8+ cells isolated from SAA patients were able to suppress colony formation <italic>in vitro</italic> (<xref rid="B129" ref-type="bibr">129</xref>). Th1-shifted cytokine secretion with elevated IFNγ, TNFα, and IL-2 levels is thought to contribute to disease pathogenesis by suppressing hematopoiesis (<xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B99" ref-type="bibr">99</xref>–<xref rid="B101" ref-type="bibr">101</xref>).</p><p>Although SAA is primarily immune-mediated, acquisition of somatic mutations and clonal hematopoiesis seem to be relevant phenomena. Clonal evolution is thought to be driven mainly by two mechanisms: (i) proliferative pressure to compensate for hematopoietic failure, and (ii) immune escape.</p><p>Best described is the presence of a so-called paroxysmal nocturnal hemoglobinuria (PNH) clone in patients with SAA. In PNH, the clonal cell population harbors a mutation in the <italic>PIGA</italic> gene and thus lacks cell surface proteins linked to a glycosylphosphatidylinositol anchor. In clinically manifest PNH, this leads to complement-mediated hemolysis and the risk of thrombosis (<xref rid="B80" ref-type="bibr">80</xref>). It is possible that <italic>PIGA</italic> mutations occur to escape autoimmunity directed against glycosylphosphatidylinositol-bound antigens. Alternatively, the clone might exist <italic>a priori</italic> and be positively selected when other hematopoietic cells are hit by autoreactive T cells in SAA. Also, copy number-neutral loss of heterozygosity of chromosome 6p is observed disproportionately frequent in SAA patients (<xref rid="B81" ref-type="bibr">81</xref>). This is thought to be a mechanism of immune-escape by deletion of antigenic HLA alleles. Finally, SAA patients have been shown to carry somatic mutations similar to those mutated in MDS (i.e., <italic>ASXL1</italic>, <italic>DNMT3A</italic>, <italic>TET2</italic>, and others), indicating transformation into secondary MDS (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B130" ref-type="bibr">130</xref>).</p></sec><sec id="S9-3"><title>B-cell precursor acute lymphoblastic leukemia</title><p>About 2% of patients with B-cell precursor acute lymphoblastic leukemia (ALL) present with pancytopenia and hypocellular BM. Usually, this prophase is transient and goes into spontaneous remission before ALL emerges with a latency of up to 9 months. Hematopoietic cells in the aplastic phase have been shown to carry the same gene mutations as the leukemic blasts (<xref rid="B131" ref-type="bibr">131</xref>, <xref rid="B132" ref-type="bibr">132</xref>).</p></sec></sec><sec id="S10"><title>Inherited Bone Marrow Failure, MDS, and SAA: The Diagnostic Challenge of a Hypocellular Marrow</title><p>One of the major challenges in pediatric hematology is the correct diagnosis of patients with pancytopenia and hypocellular BM. Once infections and other more frequent conditions resulting in a transient suppression of hematopoieisis have been excluded, the main differential diagnosis includes SAA, hypoplastic MDS, and IBMFS, such as FA and DC. Careful diagnostic work-up and accurate distinction of these entities are mandatory because they require different strategies for therapy, surveillance, and counseling. In particular, IBMFS have to be excluded since they often present as multisystem and tumor-susceptibility syndromes with limited tolerance to various therapies (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B109" ref-type="bibr">109</xref>). The diagnostic challenge is not only due to similar clinical presentation but also caused by a relevant overlap in the underlying pathophysiology. Table <xref ref-type="table" rid="T3">3</xref> shows different pathophysiological mechanisms contributing to IBMFS, MDS-RCC, and SAA to variable degrees. Further problems for the diagnostic work-up are scarce cell numbers isolated from hypocellular BM and lack of discriminating functional tests.</p><p>Knowing these hurdles, the following diagnostic criteria and workflow should be followed:
<list list-type="simple"><list-item><label>(i)</label><p>BM analysis: next to aspiration cytology, histological analysis of a trephine biopsy should be performed. RCC and SAA can be reliably differentiated in trephine biopsies (<xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B133" ref-type="bibr">133</xref>) and the respective criteria, as defined in the WHO classification 2008, are depicted in Table <xref ref-type="table" rid="T4">4</xref> (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B113" ref-type="bibr">113</xref>). Additionally, cytogenetic analysis with metaphase cytogenetics and FISH should be performed. Chromosomal aberrations indicate the presence of MDS. However, >60% of all RCC cases have a normal karyotype (<xref rid="B114" ref-type="bibr">114</xref>). Next generation sequencing will be helpful to detect clonal driver mutations indicative for MDS-RCC, but this method is still expensive and reserved for research questions.</p></list-item><list-item><label>(ii)</label><p>Exclusion of IBMFS: IBMFS and RCC frequently have overlapping morphological features. Thus, careful past medical and family history, as well as physical examination, is required to exclude presence of a multisystem disease. FA and DC should be excluded by mitomycin C stimulation and telomere measurements, respectively. Genetic testing can confirm the suspected diagnosis, but gene mutations cannot be detected in all cases. In case of the diagnosis of a defined IBMFS or a presentation that is highly suspicious for an inherited disorder, possible related stem cell donors should be carefully evaluated for signs and symptoms of the respective disease. Patients with strong evidence of multisystem disease but without genetic diagnosis might benefit from functional tests such as chromosomal breakage, cell cycle arrest, ribosomal profiling, or others. However, such tests might be technically challenging and difficult to interpret and thus are not part of standard diagnostic work-up.</p></list-item></list></p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p><bold>Morphological criteria for severe aplastic anemia and myelodysplastic syndromes, type refractory cytopenia of childhood (EWOG-MDS 2008) (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B113" ref-type="bibr">113</xref>)</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Myelodysplastic syndrome, type refractory cytopenia of childhood (MDS-RCC)</th><th align="left" rowspan="1" colspan="1">Severe aplastic anemia (SAA)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Erythropoiesis</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Patchy distribution, increased numbers of proerythroblasts (left shift), increased numbers of mitoses</td><td align="left" valign="top" rowspan="1" colspan="1">Lacking or single small focus with <10 cells, full maturation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Granulopoiesis</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Marked decrease, left shift</td><td align="left" valign="top" rowspan="1" colspan="1">Lacking or marked decrease, very few small foci with maturation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Megakaryopoiesis</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Marked decrease or absence<break></break>Micromegakaryocytes (to be detected by immunohistochemistry)</td><td align="left" valign="top" rowspan="1" colspan="1">Lacking or very few, no micromegakaryocytes or other dysplastic megakaryocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Lymphocytes</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Lymphocytes and plasma cells might be increased</td><td align="left" valign="top" rowspan="1" colspan="1">May be increased focally or dispersed</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>CD34<bold><italic>+</italic></bold> cells</bold></td><td align="left" valign="top" rowspan="1" colspan="1">No increase</td><td align="left" valign="top" rowspan="1" colspan="1">No increase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Others</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Mast cells might be increased<break></break>Adipocytic bone marrow<break></break>No increase in reticulin fibers (difference to adult MDS patients)</td><td align="left" valign="top" rowspan="1" colspan="1">After initation of immunosuppressive therapy: similar to MDS-RCC</td></tr></tbody></table></table-wrap><p>Since disorders of hypocellular BM are rare, diagnostic work-up should be performed by experienced hematologists and hematopathologists, and patients should be treated after consultation with reference centers. This ensures best care for affected patients and their families and prevents underdiagnosis of RCC and telomeropathies in SAA cohorts (<xref rid="B109" ref-type="bibr">109</xref>, <xref rid="B134" ref-type="bibr">134</xref>–<xref rid="B136" ref-type="bibr">136</xref>).</p><p>It is also important to repeatedly reevaluate patients with IBMFS and SAA, since both disorders are at risk to progress into secondary MDS. Secondary MDS can be diagnosed by an increase in blast cells or BM cellularity, despite persistent pancytopenia, and by acquisition of chromosomal aberrations.</p></sec><sec id="S11"><title>Therapeutic Approaches and Limitations</title><p>Treatment of (pan)cytopenia is based on a few symptomatic or curative therapeutic options. Symptomatic treatment includes the transfusion of blood products, such as red blood cells and platelets, and prevention or treatment of infections with antimicrobial drugs, and if indicated immunoglobulin substitutions. Granulocyte or T cell transfusions are technically feasible but restricted to very few life-threatening situations. Hematopoietic growth factors may be used to stimulate hematopoiesis and overcome reduced blood cell production. G-CSF is the therapy of choice for patients with SCN and has changed the fate of majority of children with this serious condition (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B137" ref-type="bibr">137</xref>). Today, allogeneic HSCT is limited to patients who do not respond to G-CSF or develop MDS (<xref rid="B138" ref-type="bibr">138</xref>). Although the situation is less clear, selected patients with SDS might benefit from G-CSF in case of severe neutropenia (<xref rid="B66" ref-type="bibr">66</xref>). The thrombopoietin analog eltrombopag has been successfully used in chronic ITP (<xref rid="B139" ref-type="bibr">139</xref>) and surprisingly induced multilineage responses in an early study in patients with refractory SAA (<xref rid="B140" ref-type="bibr">140</xref>). Other, less specific stimulants of hematopoiesis are the steroid prednisolone or the androgens, danazol and oxymetholone, used for DBA or DC, FA, and SAA patients, respectively (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B141" ref-type="bibr">141</xref>–<xref rid="B144" ref-type="bibr">144</xref>).</p><p>Some of the disorders described in this review require immune-modulatory or suppressive therapies. These include high dose-immunoglobulins, anti-thymocyte globulin (ATG), steroids, cyclosporine, mycophenolic acid, and others. Detailed treatment schedules for ITP, AIHA, ALPS, SLE, HLH, and others are beyond the scope of this review and described elsewhere.</p><p>Immunosuppressive therapy traditionally has been the therapy of choice for patients with SAA with no matched related donor (<xref rid="B94" ref-type="bibr">94</xref>, <xref rid="B145" ref-type="bibr">145</xref>). The best established regimen consists of ATG in combination with cyclosporine A (<xref rid="B95" ref-type="bibr">95</xref>). In 2011, a randomized trial demonstrated that the source of ATG (horse vs rabbit) is relevant and the treatment with ATG derived from horses is more effective compared to products derived from rabbits (<xref rid="B146" ref-type="bibr">146</xref>). These results have subsequently been confirmed in multiple observational studies (<xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B148" ref-type="bibr">148</xref>). Using the combination of horse ATG and cyclosporine, the response rate is approximately 60–70% with a risk of relapse or clonal evolution of 10–30 or 10–20%, respectively (<xref rid="B145" ref-type="bibr">145</xref>). Attempts to improve efficacy were based on additional treatment with sirolimus, mycophenoalte mofetil, or danazol, and did not result in significant improvements. Also, the addition of G-CSF did not result in better response rates or improved survival, and therefore is not generally recommended. Based on the observation that autoimmunity contributes to the pathophysiology of MDS (Table <xref ref-type="table" rid="T3">3</xref>) and that adult patients with hypoplastic MDS have successfully been treated with IST (<xref rid="B149" ref-type="bibr">149</xref>), selected pediatric patients with hypocellular RCC have successfully been treated with IST (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B150" ref-type="bibr">150</xref>, <xref rid="B151" ref-type="bibr">151</xref>).</p><p>Hematopoietic stem cell transplantation is a curative treatment for patients with SAA and MDS, and the hematological manifestation of IBMFS. Patients with SAA traditionally were transplanted following a conditioning regimen consisting of cyclophosphamide/ATG in the presence of a matched sibling donor with excellent results (<xref rid="B152" ref-type="bibr">152</xref>). Based on less favorable results, HSCT from an unrelated donor was only performed in patients with non-response to IST, relapse, or clonal evolution. Lately, the results of HSCT from unrelated donors have improved considerably and upfront primary HSCT from a well-matched unrelated donor might be considered in selected cases if the donor is available in an acceptable timeframe (<xref rid="B153" ref-type="bibr">153</xref>–<xref rid="B155" ref-type="bibr">155</xref>).</p><p>In RCC, the indication for HSCT is based on the severity of pancytopenia (ANC <1000/μl and/or transfusion dependency) and the presence of cytogenetic aberrations (monosomy 7, 7q-, complex karyotype). Patients with hypocellular RCC with normal karyotype are successfully treated with a reduced intensity regimen, whereas patients with cytogenetic aberrations or a normo-/hypercellular marrow require a more intensive regimen. Patients with advanced MDS should be transplanted as soon as possible following an intensive conditioning regimen (<xref rid="B118" ref-type="bibr">118</xref>, <xref rid="B156" ref-type="bibr">156</xref>, <xref rid="B157" ref-type="bibr">157</xref>).</p><p>In IBMFS, allogeneic HSCT is able to treat the hematological, and immunological manifestations of the disease. However, extrahematological manifestations, such as pulmonary fibrosis in DC, are not only not treated by this therapeutic approach but may also be an insurmountable obstacle for HSCT. In addition, the majority IBMFS are multisystem disorders with a complex pathophysiology that result in an increased sensitivity to chemotherapeutic drugs requiring a specific adaption of conditioning regimens (<xref rid="B158" ref-type="bibr">158</xref>). The careful evaluation of possible related stem cell donors is of special importance in familial disease.</p><p>Finally, it has to be mentioned that HSCT is also the only curative treatment for all forms of primary immunodeficiencies and familial HLH. Experimental approaches such as targeted gene correction are under evaluation with regard to efficacy and safety, but not yet suitable for broad application.</p><p>In summary, it is still a great challenge to find the correct diagnosis for patients with (pan)cytopenia, especially in the presence of a hypocellular BM. Better definition and differentiation between the individual inherited and acquired disorders are required to ensure adequate medical care, surveillance, and genetic counseling for affected children and their families. To this end, the underlying pathophysiological mechanisms have to be investigated in more detail. Furthermore, functional tests and biomarkers with higher specificity for individual diseases have to be developed. Finally, we recommend that all affected children should be registered in registries and/or clinical trials and treated according to general guidelines.</p></sec><sec id="S12"><title>Author Contributions</title><p>ME and BS wrote the manuscript.</p></sec><sec id="S13"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doulatov</surname><given-names>S</given-names></name><name><surname>Notta</surname><given-names>F</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Dick</surname><given-names>JE</given-names></name></person-group><article-title>Hematopoiesis: a human perspective</article-title>. <source>Cell Stem Cell</source> (<year>2012</year>) <volume>10</volume>:<fpage>120</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/j.stem.2012.01.006</pub-id><pub-id pub-id-type="pmid">22305562</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Dick</surname><given-names>JE</given-names></name></person-group><article-title>Molecular and functional characterization of early human hematopoiesis</article-title>. <source>Ann N Y Acad Sci</source> (<year>2012</year>) <volume>1266</volume>:<fpage>68</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06577.x</pub-id><pub-id pub-id-type="pmid">22901258</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjuan-Pla</surname><given-names>A</given-names></name><name><surname>Macaulay</surname><given-names>IC</given-names></name><name><surname>Jensen</surname><given-names>CT</given-names></name><name><surname>Woll</surname><given-names>PS</given-names></name><name><surname>Luis</surname><given-names>TC</given-names></name><name><surname>Mead</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy</article-title>. <source>Nature</source> (<year>2013</year>) <volume>502</volume>:<fpage>232</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nature12495</pub-id><pub-id pub-id-type="pmid">23934107</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janus</surname><given-names>J</given-names></name><name><surname>Moerschel</surname><given-names>SK</given-names></name></person-group><article-title>Evaluation of anemia in children</article-title>. <source>Am Fam Physician</source> (<year>2010</year>) <volume>81</volume>:<fpage>1462</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">20540485</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balduini</surname><given-names>CL</given-names></name><name><surname>Savoia</surname><given-names>A</given-names></name></person-group><article-title>Genetics of familial forms of thrombocytopenia</article-title>. <source>Hum Genet</source> (<year>2012</year>) <volume>131</volume>:<fpage>1821</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1007/s00439-012-1215-x</pub-id><pub-id pub-id-type="pmid">22886561</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blajchman</surname><given-names>MA</given-names></name><name><surname>Senyi</surname><given-names>AF</given-names></name><name><surname>Hirsh</surname><given-names>J</given-names></name><name><surname>Genton</surname><given-names>E</given-names></name><name><surname>George</surname><given-names>JN</given-names></name></person-group>. <article-title>Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets</article-title>. <source>J Clin Invest</source> (<year>1981</year>) <volume>68</volume>:<fpage>1289</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1172/JCI110375</pub-id><pub-id pub-id-type="pmid">7298853</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skokowa</surname><given-names>J</given-names></name><name><surname>Germeshausen</surname><given-names>M</given-names></name><name><surname>Zeidler</surname><given-names>C</given-names></name><name><surname>Welte</surname><given-names>K</given-names></name></person-group>. <article-title>Severe congenital neutropenia: inheritance and pathophysiology</article-title>. <source>Curr Opin Hematol</source> (<year>2007</year>) <volume>14</volume>:<fpage>22</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/00062752-200701000-00006</pub-id><pub-id pub-id-type="pmid">17133096</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Herz</surname><given-names>W</given-names></name><name><surname>Bousfiha</surname><given-names>A</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Chatila</surname><given-names>T</given-names></name><name><surname>Conley</surname><given-names>ME</given-names></name><name><surname>Cunningham-Rundles</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>162</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00162</pub-id><pub-id pub-id-type="pmid">24795713</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostoufi-Zadeh</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>LM</given-names></name><name><surname>Driscoll</surname><given-names>SG</given-names></name></person-group>. <article-title>Nonimmune hydrops fetalis: a challenge in perinatal pathology</article-title>. <source>Hum Pathol</source> (<year>1985</year>) <volume>16</volume>:<fpage>785</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S0046-8177(85)80249-5</pub-id><pub-id pub-id-type="pmid">4018776</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>V</given-names></name><name><surname>Balachandran</surname><given-names>C</given-names></name><name><surname>Lonikar</surname><given-names>V</given-names></name></person-group>. <article-title>Blueberry muffin baby: a pictoral differential diagnosis</article-title>. <source>Dermatol Online J</source> (<year>2008</year>) <volume>14</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">18700111</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>A</given-names></name><name><surname>Notarangelo</surname><given-names>LD</given-names></name><name><surname>Roifman</surname><given-names>CM</given-names></name></person-group>. <article-title>Omenn syndrome: inflammation in leaky severe combined immunodeficiency</article-title>. <source>J Allergy Clin Immunol</source> (<year>2008</year>) <volume>122</volume>:<fpage>1082</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2008.09.037</pub-id><pub-id pub-id-type="pmid">18992930</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valent</surname><given-names>P</given-names></name></person-group>. <article-title>Low blood counts: immune mediated, idiopathic, or myelodysplasia</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2012</year>) <volume>2012</volume>:<fpage>485</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2012.1.485</pub-id><pub-id pub-id-type="pmid">23233623</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>M</given-names></name><name><surname>Perricone</surname><given-names>C</given-names></name><name><surname>Ortega-Hernandez</surname><given-names>OD</given-names></name><name><surname>Perricone</surname><given-names>R</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name></person-group>. <article-title>Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines</article-title>. <source>Lupus</source> (<year>2014</year>) <volume>23</volume>:<fpage>554</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1177/0961203313499959</pub-id><pub-id pub-id-type="pmid">24763539</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>SE</given-names></name><name><surname>Sachais</surname><given-names>BS</given-names></name></person-group>. <article-title>Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia</article-title>. <source>Curr Opin Hematol</source> (<year>2014</year>) <volume>21</volume>:<fpage>380</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1097/MOH.0000000000000066</pub-id><pub-id pub-id-type="pmid">24992313</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youinou</surname><given-names>P</given-names></name><name><surname>Jamin</surname><given-names>C</given-names></name><name><surname>Le Pottier</surname><given-names>L</given-names></name><name><surname>Renaudineau</surname><given-names>Y</given-names></name><name><surname>Hillion</surname><given-names>S</given-names></name><name><surname>Pers</surname><given-names>JO</given-names></name></person-group>. <article-title>Diagnostic criteria for autoimmune neutropenia</article-title>. <source>Autoimmun Rev</source> (<year>2014</year>) <volume>13</volume>:<fpage>574</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.autrev.2014.01.001</pub-id><pub-id pub-id-type="pmid">24418296</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bass</surname><given-names>GF</given-names></name><name><surname>Tuscano</surname><given-names>ET</given-names></name><name><surname>Tuscano</surname><given-names>JM</given-names></name></person-group>. <article-title>Diagnosis and classification of autoimmune hemolytic anemia</article-title>. <source>Autoimmun Rev</source> (<year>2014</year>) <volume>13</volume>:<fpage>560</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/j.autrev.2013.11.010</pub-id><pub-id pub-id-type="pmid">24418298</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>E</given-names></name><name><surname>Cramer</surname><given-names>E</given-names></name><name><surname>Rivière</surname><given-names>C</given-names></name><name><surname>Rameau</surname><given-names>P</given-names></name><name><surname>Louache</surname><given-names>F</given-names></name><name><surname>Guichard</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation</article-title>. <source>Blood</source> (<year>1999</year>) <volume>94</volume>:<fpage>509</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">10397718</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sponzilli</surname><given-names>I</given-names></name><name><surname>Notarangelo</surname><given-names>LD</given-names></name></person-group>. <article-title>Severe combined immunodeficiency (SCID): from molecular basis to clinical management</article-title>. <source>Acta Biomed</source> (<year>2011</year>) <volume>82</volume>:<fpage>5</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">22069950</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>DC</given-names></name><name><surname>Cottle</surname><given-names>TE</given-names></name><name><surname>Fier</surname><given-names>CJ</given-names></name><name><surname>Bolyard</surname><given-names>AA</given-names></name><name><surname>Bonilla</surname><given-names>MA</given-names></name><name><surname>Boxer</surname><given-names>LA</given-names></name><etal></etal></person-group><article-title>Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry</article-title>. <source>Am J Hematol</source> (<year>2003</year>) <volume>72</volume>:<fpage>82</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/ajh.10255</pub-id><pub-id pub-id-type="pmid">12555210</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeidler</surname><given-names>C</given-names></name><name><surname>Germeshausen</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Welte</surname><given-names>K</given-names></name></person-group>. <article-title>Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia</article-title>. <source>Br J Haematol</source> (<year>2009</year>) <volume>144</volume>:<fpage>459</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2141.2008.07425.x</pub-id><pub-id pub-id-type="pmid">19120359</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>C</given-names></name></person-group>. <article-title>Congenital neutropenia</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2009</year>):<fpage>344</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2009.1.344</pub-id><pub-id pub-id-type="pmid">20008220</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makaryan</surname><given-names>V</given-names></name><name><surname>Zeidler</surname><given-names>C</given-names></name><name><surname>Bolyard</surname><given-names>AA</given-names></name><name><surname>Skokowa</surname><given-names>J</given-names></name><name><surname>Rodger</surname><given-names>E</given-names></name><name><surname>Kelley</surname><given-names>ML</given-names></name><etal></etal></person-group><article-title>The diversity of mutations and clinical outcomes for ELANE-associated neutropenia</article-title>. <source>Curr Opin Hematol</source> (<year>2015</year>) <volume>22</volume>:<fpage>3</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1097/MOH.0000000000000105</pub-id><pub-id pub-id-type="pmid">25427142</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishnani</surname><given-names>PS</given-names></name><name><surname>Austin</surname><given-names>SL</given-names></name><name><surname>Abdenur</surname><given-names>JE</given-names></name><name><surname>Arn</surname><given-names>P</given-names></name><name><surname>Bali</surname><given-names>DS</given-names></name><name><surname>Boney</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics</article-title>. <source>Genet Med</source> (<year>2014</year>) <volume>16</volume>:<fpage>e1</fpage>.<pub-id pub-id-type="doi">10.1038/gim.2014.128</pub-id><pub-id pub-id-type="pmid">25356975</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CC</given-names></name><name><surname>Traynor</surname><given-names>D</given-names></name><name><surname>Basse</surname><given-names>N</given-names></name><name><surname>Kay</surname><given-names>RR</given-names></name><name><surname>Warren</surname><given-names>AJ</given-names></name></person-group>. <article-title>Defective ribosome assembly in Shwachman-Diamond syndrome</article-title>. <source>Blood</source> (<year>2011</year>) <volume>118</volume>:<fpage>4305</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-06-353938</pub-id><pub-id pub-id-type="pmid">21803848</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalev</surname><given-names>H</given-names></name><name><surname>Kapelushnik</surname><given-names>J</given-names></name><name><surname>Moser</surname><given-names>A</given-names></name><name><surname>Dgany</surname><given-names>O</given-names></name><name><surname>Krasnov</surname><given-names>T</given-names></name><name><surname>Tamary</surname><given-names>H</given-names></name></person-group>. <article-title>A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I</article-title>. <source>J Pediatr Hematol Oncol</source> (<year>2004</year>) <volume>26</volume>:<fpage>746</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/00043426-200411000-00011</pub-id><pub-id pub-id-type="pmid">15543010</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname><given-names>S</given-names></name></person-group>. <article-title>Diamond Blackfan anemia</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2011</year>) <volume>2011</volume>:<fpage>487</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2011.1.487</pub-id><pub-id pub-id-type="pmid">22160079</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivella</surname><given-names>S</given-names></name></person-group><article-title>Ineffective erythropoiesis and thalassemias</article-title>. <source>Curr Opin Hematol</source> (<year>2009</year>) <volume>16</volume>:<fpage>187</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1097/MOH.0b013e32832990a4</pub-id><pub-id pub-id-type="pmid">19318943</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>K</given-names></name><name><surname>Hirokawa</surname><given-names>M</given-names></name><name><surname>Fujishima</surname><given-names>N</given-names></name></person-group><article-title>Diagnosis and management of acquired pure red cell aplasia</article-title>. <source>Hematol Oncol Clin North Am</source> (<year>2009</year>) <volume>23</volume>:<fpage>249</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1016/j.hoc.2009.01.009</pub-id><pub-id pub-id-type="pmid">19327582</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangat</surname><given-names>N</given-names></name><name><surname>Wolanskyj</surname><given-names>AP</given-names></name></person-group>. <article-title>Anemia of chronic disease</article-title>. <source>Semin Hematol</source> (<year>2013</year>) <volume>50</volume>:<fpage>232</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1053/j.seminhematol.2013.06.006</pub-id><pub-id pub-id-type="pmid">23953340</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sankaran</surname><given-names>VG</given-names></name><name><surname>Weiss</surname><given-names>MJ</given-names></name></person-group><article-title>Anemia: progress in molecular mechanisms and therapies</article-title>. <source>Nat Med</source> (<year>2015</year>) <volume>21</volume>:<fpage>221</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3814</pub-id><pub-id pub-id-type="pmid">25742458</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geddis</surname><given-names>AE</given-names></name></person-group>. <article-title>Congenital amegakaryocytic thrombocytopenia</article-title>. <source>Pediatr Blood Cancer</source> (<year>2011</year>) <volume>57</volume>:<fpage>199</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.22927</pub-id><pub-id pub-id-type="pmid">21337678</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albers</surname><given-names>CA</given-names></name><name><surname>Newbury-Ecob</surname><given-names>R</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Ghevaert</surname><given-names>C</given-names></name></person-group>. <article-title>New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome</article-title>. <source>Curr Opin Genet Dev</source> (<year>2013</year>) <volume>23</volume>:<fpage>316</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.gde.2013.02.015</pub-id><pub-id pub-id-type="pmid">23602329</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>C</given-names></name></person-group><article-title>Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML)</article-title>. <source>Leuk Res</source> (<year>2010</year>) <volume>34</volume>:<fpage>141</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="doi">10.1016/j.leukres.2009.07.037</pub-id><pub-id pub-id-type="pmid">19695705</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diz-Kucukkaya</surname><given-names>R</given-names></name></person-group>. <article-title>Inherited platelet disorders including Glanzmann thrombasthenia and Bernard-Soulier syndrome</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2013</year>) <volume>2013</volume>:<fpage>268</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2013.1.268</pub-id><pub-id pub-id-type="pmid">24319190</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname><given-names>R</given-names></name><name><surname>Muñiz-Díaz</surname><given-names>E</given-names></name><name><surname>Arilla</surname><given-names>M</given-names></name><name><surname>Ibáñez</surname><given-names>M</given-names></name><name><surname>Altés</surname><given-names>A</given-names></name><name><surname>Guanyabens</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Combined autoimmune cytopenias</article-title>. <source>Haematologica</source> (<year>1995</year>) <volume>80</volume>:<fpage>305</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">7590498</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidel</surname><given-names>MG</given-names></name></person-group>. <article-title>Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment</article-title>. <source>Blood</source> (<year>2014</year>) <volume>124</volume>:<fpage>2337</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2014-06-583260</pub-id><pub-id pub-id-type="pmid">25163701</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seif</surname><given-names>AE</given-names></name><name><surname>Manno</surname><given-names>CS</given-names></name><name><surname>Sheen</surname><given-names>C</given-names></name><name><surname>Grupp</surname><given-names>SA</given-names></name><name><surname>Teachey</surname><given-names>DT</given-names></name></person-group>. <article-title>Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study</article-title>. <source>Blood</source> (<year>2010</year>) <volume>115</volume>:<fpage>2142</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2009-08-239525</pub-id><pub-id pub-id-type="pmid">20068224</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teachey</surname><given-names>DT</given-names></name></person-group><article-title>New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome</article-title>. <source>Curr Opin Pediatr</source> (<year>2012</year>) <volume>24</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/MOP.0b013e32834ea739</pub-id><pub-id pub-id-type="pmid">22157362</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleisher</surname><given-names>TA</given-names></name><name><surname>Oliveira</surname><given-names>JB</given-names></name></person-group>. <article-title>Monogenic defects in lymphocyte apoptosis</article-title>. <source>Curr Opin Allergy Clin Immunol</source> (<year>2012</year>) <volume>12</volume>:<fpage>609</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1097/ACI.0b013e3283588da0</pub-id><pub-id pub-id-type="pmid">22918222</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>JB</given-names></name></person-group>. <article-title>The expanding spectrum of the autoimmune lymphoproliferative syndromes</article-title>. <source>Curr Opin Pediatr</source> (<year>2013</year>) <volume>25</volume>:<fpage>722</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1097/MOP.0000000000000032</pub-id><pub-id pub-id-type="pmid">24240292</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbsky</surname><given-names>JW</given-names></name><name><surname>Chatila</surname><given-names>TA</given-names></name></person-group>. <article-title>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases</article-title>. <source>Curr Opin Pediatr</source> (<year>2013</year>) <volume>25</volume>:<fpage>708</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1097/MOP.0000000000000029</pub-id><pub-id pub-id-type="pmid">24240290</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraes-Vasconcelos</surname><given-names>D</given-names></name><name><surname>Costa-Carvalho</surname><given-names>BT</given-names></name><name><surname>Torgerson</surname><given-names>TR</given-names></name><name><surname>Ochs</surname><given-names>HD</given-names></name></person-group><article-title>Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED</article-title>. <source>J Clin Immunol</source> (<year>2008</year>) <volume>28</volume>(<issue>Suppl 1</issue>):<fpage>S11</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1007/s10875-008-9176-5</pub-id><pub-id pub-id-type="pmid">18264745</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janka</surname><given-names>GE</given-names></name><name><surname>Lehmberg</surname><given-names>K</given-names></name></person-group>. <article-title>Hemophagocytic lymphohistiocytosis: pathogenesis and treatment</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2013</year>) <volume>2013</volume>:<fpage>605</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2013.1.605</pub-id><pub-id pub-id-type="pmid">24319239</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmberg</surname><given-names>K</given-names></name><name><surname>Ehl</surname><given-names>S</given-names></name></person-group>. <article-title>Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis</article-title>. <source>Br J Haematol</source> (<year>2013</year>) <volume>160</volume>:<fpage>275</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1111/bjh.12138</pub-id><pub-id pub-id-type="pmid">23206255</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohlfeld</surname><given-names>P</given-names></name><name><surname>Forestier</surname><given-names>F</given-names></name><name><surname>Kaplan</surname><given-names>C</given-names></name><name><surname>Tissot</surname><given-names>JD</given-names></name><name><surname>Daffos</surname><given-names>F</given-names></name></person-group>. <article-title>Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings</article-title>. <source>Blood</source> (<year>1994</year>) <volume>84</volume>: <fpage>1851</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">8080991</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulusoy</surname><given-names>E</given-names></name><name><surname>Tüfekçi</surname><given-names>O</given-names></name><name><surname>Duman</surname><given-names>N</given-names></name><name><surname>Kumral</surname><given-names>A</given-names></name><name><surname>Irken</surname><given-names>G</given-names></name><name><surname>Oren</surname><given-names>H</given-names></name></person-group>. <article-title>Thrombocytopenia in neonates: causes and outcomes</article-title>. <source>Ann Hematol</source> (<year>2013</year>) <volume>92</volume>:<fpage>961</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/s00277-013-1726-0</pub-id><pub-id pub-id-type="pmid">23519382</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>EP</given-names></name><name><surname>de Haan</surname><given-names>TR</given-names></name><name><surname>Kroes</surname><given-names>AC</given-names></name><name><surname>Beersma</surname><given-names>MF</given-names></name><name><surname>Oepkes</surname><given-names>D</given-names></name><name><surname>Walther</surname><given-names>FJ</given-names></name></person-group><article-title>Parvovirus B19 infection in pregnancy</article-title>. <source>J Clin Virol</source> (<year>2006</year>) <volume>36</volume>:<fpage>1</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.jcv.2006.01.004</pub-id><pub-id pub-id-type="pmid">16488187</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chisaka</surname><given-names>H</given-names></name><name><surname>Morita</surname><given-names>E</given-names></name><name><surname>Yaegashi</surname><given-names>N</given-names></name><name><surname>Sugamura</surname><given-names>K</given-names></name></person-group>. <article-title>Parvovirus B19 and the pathogenesis of anaemia</article-title>. <source>Rev Med Virol</source> (<year>2003</year>) <volume>13</volume>:<fpage>347</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1002/rmv.395</pub-id><pub-id pub-id-type="pmid">14625883</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>H</given-names></name><name><surname>Phillips</surname><given-names>N</given-names></name><name><surname>Riste</surname><given-names>M</given-names></name></person-group><article-title>Visceral leishmaniasis with haemophagocytic lymphohistiocytosis: the importance of scrutinising your samples</article-title>. <source>Br J Haematol</source> (<year>2013</year>) <volume>162</volume>:<fpage>146</fpage><pub-id pub-id-type="doi">10.1111/bjh.12412</pub-id><pub-id pub-id-type="pmid">23815374</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>SF</given-names></name><name><surname>Bogdan</surname><given-names>C</given-names></name><name><surname>Beutel</surname><given-names>K</given-names></name><name><surname>Behnisch</surname><given-names>W</given-names></name><name><surname>Greiner</surname><given-names>J</given-names></name><name><surname>Henning</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area</article-title>. <source>J Pediatr</source> (<year>2014</year>) <volume>165</volume>:<fpage>147</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2014.03.047</pub-id><pub-id pub-id-type="pmid">24797953</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeb</surname><given-names>JA</given-names></name><name><surname>Zahid</surname><given-names>B</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Gul</surname><given-names>Z</given-names></name></person-group>. <article-title>Pancytopenia in children: a 6-year spectrum of patients admitted to Pediatric Department of Rehman Medical Institute, Peshawar</article-title>. <source>Pak J Med Sci.</source> (<year>2013</year>) <volume>29</volume>:<fpage>1153</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.12669/pjms.295.3865</pub-id><pub-id pub-id-type="pmid">24353710</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belen</surname><given-names>B</given-names></name><name><surname>Hismi</surname><given-names>BO</given-names></name><name><surname>Kocak</surname><given-names>U</given-names></name></person-group>. <article-title>Severe vitamin B12 deficiency with pancytopenia, hepatosplenomegaly and leukoerythroblastosis in two Syrian refugee infants: a challenge to differentiate from acute leukaemia</article-title>. <source>BMJ Case Rep</source> (<year>2014</year>) <volume>2014</volume>.<pub-id pub-id-type="doi">10.1136/bcr-2014-203742</pub-id><pub-id pub-id-type="pmid">24599434</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlacher</surname><given-names>M</given-names></name><name><surname>Grünert</surname><given-names>SC</given-names></name><name><surname>Cseh</surname><given-names>A</given-names></name><name><surname>Steinfeld</surname><given-names>R</given-names></name><name><surname>Salzer</surname><given-names>U</given-names></name><name><surname>Lausch</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>Reversible pancytopenia and immunodeficiency in a patient with hereditary folate malabsorption</article-title>. <source>Pediatr Blood Cancer</source> (<year>2015</year>) <volume>62</volume>(<issue>6</issue>):<fpage>1091</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.25364</pub-id><pub-id pub-id-type="pmid">25504888</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ida</surname><given-names>H</given-names></name><name><surname>Rennert</surname><given-names>OM</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Maekawa</surname><given-names>K</given-names></name><name><surname>Eto</surname><given-names>Y</given-names></name></person-group>. <article-title>Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients</article-title>. <source>Blood Cells Mol Dis</source> (<year>1998</year>) <volume>24</volume>:<fpage>73</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1006/bcmd.1998.0172</pub-id><pub-id pub-id-type="pmid">9541479</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>Z</given-names></name><name><surname>Savarirayan</surname><given-names>R</given-names></name></person-group>. <article-title>Osteopetrosis</article-title>. <source>Orphanet J Rare Dis</source> (<year>2009</year>) <volume>4</volume>:<fpage>5</fpage>.<pub-id pub-id-type="doi">10.1186/1750-1172-4-5</pub-id><pub-id pub-id-type="pmid">19232111</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>BP</given-names></name></person-group>. <article-title>Diagnosis, genetics, and management of inherited bone marrow failure syndromes</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2007</year>) <volume>2007</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2007.1.29</pub-id><pub-id pub-id-type="pmid">18024606</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pannicke</surname><given-names>U</given-names></name><name><surname>Hönig</surname><given-names>M</given-names></name><name><surname>Hess</surname><given-names>I</given-names></name><name><surname>Friesen</surname><given-names>C</given-names></name><name><surname>Holzmann</surname><given-names>K</given-names></name><name><surname>Rump</surname><given-names>EM</given-names></name><etal></etal></person-group><article-title>Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2</article-title>. <source>Nat Genet</source> (<year>2009</year>) <volume>41</volume>:<fpage>101</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/ng.265</pub-id><pub-id pub-id-type="pmid">19043417</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagresle-Peyrou</surname><given-names>C</given-names></name><name><surname>Six</surname><given-names>EM</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name><name><surname>Rieux-Laucat</surname><given-names>F</given-names></name><name><surname>Michel</surname><given-names>V</given-names></name><name><surname>Ditadi</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness</article-title>. <source>Nat Genet</source> (<year>2009</year>) <volume>41</volume>:<fpage>106</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1038/ng.278</pub-id><pub-id pub-id-type="pmid">19043416</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soulier</surname><given-names>J</given-names></name></person-group>. <article-title>Fanconi anemia</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2011</year>) <volume>2011</volume>:<fpage>492</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2011.1.492</pub-id><pub-id pub-id-type="pmid">22160080</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervenka</surname><given-names>J</given-names></name><name><surname>Arthur</surname><given-names>D</given-names></name><name><surname>Yasis</surname><given-names>C</given-names></name></person-group>. <article-title>Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia</article-title>. <source>Pediatrics</source> (<year>1981</year>) <volume>67</volume>:<fpage>119</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">7243420</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dokal</surname><given-names>I</given-names></name></person-group>. <article-title>Dyskeratosis congenita</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2011</year>) <volume>2011</volume>:<fpage>480</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2011.1.480</pub-id><pub-id pub-id-type="pmid">22160078</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Marrone</surname><given-names>A</given-names></name><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Walne</surname><given-names>A</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group>. <article-title>Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation</article-title>. <source>Blood</source> (<year>2006</year>) <volume>107</volume>:<fpage>2680</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-07-2622</pub-id><pub-id pub-id-type="pmid">16332973</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceccaldi</surname><given-names>R</given-names></name><name><surname>Briot</surname><given-names>D</given-names></name><name><surname>Larghero</surname><given-names>J</given-names></name><name><surname>Vasquez</surname><given-names>N</given-names></name><name><surname>Dubois d’Enghien</surname><given-names>C</given-names></name><name><surname>Chamousset</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Spontaneous abrogation of the G(2)DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<fpage>184</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1172/JCI43836</pub-id><pub-id pub-id-type="pmid">21183791</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagby</surname><given-names>GC</given-names></name><name><surname>Meyers</surname><given-names>G</given-names></name></person-group>. <article-title>Bone marrow failure as a risk factor for clonal evolution: prospects for leukemia prevention</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2007</year>) <volume>2007</volume>(<issue>1</issue>):<fpage>40</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2007.1.40</pub-id><pub-id pub-id-type="pmid">18024607</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>BP</given-names></name><name><surname>Giri</surname><given-names>N</given-names></name><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Peters</surname><given-names>JA</given-names></name><name><surname>Loud</surname><given-names>JT</given-names></name><name><surname>Leathwood</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study</article-title>. <source>Br J Haematol</source> (<year>2010</year>) <volume>150</volume>:<fpage>179</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2141.2010.08212.x</pub-id><pub-id pub-id-type="pmid">20507306</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name><name><surname>Bolyard</surname><given-names>AA</given-names></name><name><surname>Bonilla</surname><given-names>MA</given-names></name><name><surname>Boxer</surname><given-names>LA</given-names></name><name><surname>Cham</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy</article-title>. <source>Blood</source> (<year>2006</year>) <volume>107</volume>:<fpage>4628</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-11-4370</pub-id><pub-id pub-id-type="pmid">16497969</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanraj</surname><given-names>S</given-names></name><name><surname>Manji</surname><given-names>A</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name><name><surname>Favre</surname><given-names>H</given-names></name><name><surname>Loh</surname><given-names>ML</given-names></name><etal></etal></person-group><article-title>Molecular characteristics of a pancreatic adenocarcinoma associated with Shwachman-Diamond syndrome</article-title>. <source>Pediatr Blood Cancer</source> (<year>2013</year>) <volume>60</volume>:<fpage>754</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.24453</pub-id><pub-id pub-id-type="pmid">23303473</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamary</surname><given-names>H</given-names></name><name><surname>Nishri</surname><given-names>D</given-names></name><name><surname>Yacobovich</surname><given-names>J</given-names></name><name><surname>Zilber</surname><given-names>R</given-names></name><name><surname>Dgany</surname><given-names>O</given-names></name><name><surname>Krasnov</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry</article-title>. <source>Haematologica</source> (<year>2010</year>) <volume>95</volume>:<fpage>1300</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3324/haematol.2009.018119</pub-id><pub-id pub-id-type="pmid">20435624</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camitta</surname><given-names>BM</given-names></name><name><surname>Rock</surname><given-names>A</given-names></name></person-group>. <article-title>Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndrome</article-title>. <source>Am J Pediatr Hematol Oncol</source> (<year>1993</year>) <volume>15</volume>:<fpage>335</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">8328649</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachos</surname><given-names>A</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Atsidaftos</surname><given-names>E</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name><name><surname>Lipton</surname><given-names>JM</given-names></name></person-group>. <article-title>Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>:<fpage>3815</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-08-375972</pub-id><pub-id pub-id-type="pmid">22362038</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taskinen</surname><given-names>M</given-names></name><name><surname>Ranki</surname><given-names>A</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Jeskanen</surname><given-names>L</given-names></name><name><surname>Kaitila</surname><given-names>I</given-names></name><name><surname>Mäkitie</surname><given-names>O</given-names></name></person-group>. <article-title>Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma</article-title>. <source>Am J Med Genet A</source> (<year>2008</year>) <volume>146A</volume>:<fpage>2370</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1002/ajmg.a.32478</pub-id><pub-id pub-id-type="pmid">18698627</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>BB</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group>. <article-title>The DNA damage response: putting checkpoints in perspective</article-title>. <source>Nature</source> (<year>2000</year>) <volume>408</volume>:<fpage>433</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/35044005</pub-id><pub-id pub-id-type="pmid">11100718</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceccaldi</surname><given-names>R</given-names></name><name><surname>Parmar</surname><given-names>K</given-names></name><name><surname>Mouly</surname><given-names>E</given-names></name><name><surname>Delord</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Regairaz</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells</article-title>. <source>Cell Stem Cell</source> (<year>2012</year>) <volume>11</volume>:<fpage>36</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1016/j.stem.2012.05.013</pub-id><pub-id pub-id-type="pmid">22683204</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Pater</surname><given-names>E</given-names></name><name><surname>Kaimakis</surname><given-names>P</given-names></name><name><surname>Vink</surname><given-names>CS</given-names></name><name><surname>Yokomizo</surname><given-names>T</given-names></name><name><surname>Yamada-Inagawa</surname><given-names>T</given-names></name><name><surname>van der Linden</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Gata2 is required for HSC generation and survival</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>:<fpage>2843</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20130751</pub-id><pub-id pub-id-type="pmid">24297996</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kissa</surname><given-names>K</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name></person-group>. <article-title>Blood stem cells emerge from aortic endothelium by a novel type of cell transition</article-title>. <source>Nature</source> (<year>2010</year>) <volume>464</volume>:<fpage>112</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature08761</pub-id><pub-id pub-id-type="pmid">20154732</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazzola</surname><given-names>M</given-names></name><name><surname>Della Porta</surname><given-names>MG</given-names></name><name><surname>Malcovati</surname><given-names>L</given-names></name></person-group>. <article-title>The genetic basis of myelodysplasia and its clinical relevance</article-title>. <source>Blood</source> (<year>2013</year>) <volume>122</volume>:<fpage>4021</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-09-381665</pub-id><pub-id pub-id-type="pmid">24136165</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>McLellan</surname><given-names>MD</given-names></name><name><surname>Johnson</surname><given-names>KJ</given-names></name><name><surname>Wendl</surname><given-names>MC</given-names></name><etal></etal></person-group><article-title>Age-related mutations associated with clonal hematopoietic expansion and malignancies</article-title>. <source>Nat Med</source> (<year>2014</year>) <volume>20</volume>:<fpage>1472</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3733</pub-id><pub-id pub-id-type="pmid">25326804</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hirabayashi</surname><given-names>S</given-names></name><name><surname>Strahm</surname><given-names>B</given-names></name><name><surname>Urbaniak</surname><given-names>S</given-names></name><name><surname>Karow</surname><given-names>A</given-names></name><name><surname>Cseh</surname><given-names>A</given-names></name><name><surname>van den Heuvel-Eibrink</surname><given-names>MM</given-names></name><etal></etal></person-group><article-title>High frequency of GATA2 mutations in children with non-familial MDS and monosomy 7</article-title>. <source>54th ASH Annual Meeting</source>. <publisher-loc>Atlanta</publisher-loc> (<year>2012</year>). Ref Type: Generic.</mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Osato</surname><given-names>M</given-names></name><name><surname>Cottles</surname><given-names>GM</given-names></name><name><surname>Yanagida</surname><given-names>M</given-names></name><name><surname>Asou</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis</article-title>. <source>Blood</source> (<year>2002</year>) <volume>99</volume>:<fpage>1364</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1182/blood.V99.4.1364</pub-id><pub-id pub-id-type="pmid">11830488</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Heuvel-Eibrink</surname><given-names>MM</given-names></name></person-group><article-title>Paroxysmal nocturnal hemoglobinuria in children</article-title>. <source>Paediatr Drugs</source> (<year>2007</year>) <volume>9</volume>:<fpage>11</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2165/00148581-200709010-00002</pub-id><pub-id pub-id-type="pmid">17291133</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katagiri</surname><given-names>T</given-names></name><name><surname>Sato-Otsubo</surname><given-names>A</given-names></name><name><surname>Kashiwase</surname><given-names>K</given-names></name><name><surname>Morishima</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><etal></etal></person-group><article-title>Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia</article-title>. <source>Blood</source> (<year>2011</year>) <volume>118</volume>:<fpage>6601</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-07-365189</pub-id><pub-id pub-id-type="pmid">21963603</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulasekararaj</surname><given-names>AG</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>AE</given-names></name><name><surname>Mohamedali</surname><given-names>AM</given-names></name><name><surname>Mian</surname><given-names>S</given-names></name><name><surname>Gandhi</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome</article-title>. <source>Blood</source> (<year>2014</year>) <volume>124</volume>:<fpage>2698</fpage>–<lpage>704</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2014-05-574889</pub-id><pub-id pub-id-type="pmid">25139356</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korthof</surname><given-names>ET</given-names></name><name><surname>Svahn</surname><given-names>J</given-names></name><name><surname>Peffault de Latour</surname><given-names>R</given-names></name><name><surname>Terranova</surname><given-names>P</given-names></name><name><surname>Moins-Teisserenc</surname><given-names>H</given-names></name><name><surname>Socié</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients</article-title>. <source>Am J Hematol</source> (<year>2013</year>) <volume>88</volume>:<fpage>472</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1002/ajh.23435</pub-id><pub-id pub-id-type="pmid">23483621</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epling-Burnette</surname><given-names>PK</given-names></name><name><surname>Painter</surname><given-names>JS</given-names></name><name><surname>Rollison</surname><given-names>DE</given-names></name><name><surname>Ku</surname><given-names>E</given-names></name><name><surname>Vendron</surname><given-names>D</given-names></name><name><surname>Widen</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome</article-title>. <source>Leukemia</source> (<year>2007</year>) <volume>21</volume>:<fpage>659</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1038/sj.leu.2404590</pub-id><pub-id pub-id-type="pmid">17301813</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vries</surname><given-names>AC</given-names></name><name><surname>Langerak</surname><given-names>AW</given-names></name><name><surname>Verhaaf</surname><given-names>B</given-names></name><name><surname>Niemeyer</surname><given-names>CM</given-names></name><name><surname>Stary</surname><given-names>J</given-names></name><name><surname>Schmiegelow</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia</article-title>. <source>Leukemia</source> (<year>2008</year>) <volume>22</volume>:<fpage>1170</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/leu.2008.23</pub-id><pub-id pub-id-type="pmid">18323803</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannouli</surname><given-names>S</given-names></name><name><surname>Voulgarelis</surname><given-names>M</given-names></name></person-group>. <article-title>A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases</article-title>. <source>Expert Rev Clin Immunol.</source> (<year>2014</year>) <volume>10</volume>:<fpage>1679</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1586/1744666X.2014.970181</pub-id><pub-id pub-id-type="pmid">25308147</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimi</surname><given-names>A</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Führer</surname><given-names>M</given-names></name><name><surname>Bergsträsser</surname><given-names>E</given-names></name><name><surname>Göbel</surname><given-names>U</given-names></name><name><surname>Sykora</surname><given-names>KW</given-names></name><etal></etal></person-group><article-title>Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia</article-title>. <source>Haematologica</source> (<year>2007</year>) <volume>92</volume>:<fpage>397</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="doi">10.3324/haematol.10683</pub-id><pub-id pub-id-type="pmid">17339190</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Katsanis</surname><given-names>E</given-names></name></person-group><article-title>The complex pathophysiology of acquired aplastic anemia</article-title>. <source>Clin Exp Immunol</source> (<year>2015</year>) <volume>180</volume>(<issue>3</issue>):<fpage>361</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1111/cei.12605</pub-id><pub-id pub-id-type="pmid">25683099</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kordasti</surname><given-names>S</given-names></name><name><surname>Marsh</surname><given-names>J</given-names></name><name><surname>Al-Khan</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Mohamedali</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Functional characterization of CD4+ T cells in aplastic anemia</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>:<fpage>2033</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-08-368308</pub-id><pub-id pub-id-type="pmid">22138514</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name></person-group>. <article-title>Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia</article-title>. <source>Acta Haematol</source> (<year>2012</year>) <volume>128</volume>:<fpage>23</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1159/000337094</pub-id><pub-id pub-id-type="pmid">22572536</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Führer</surname><given-names>M</given-names></name><name><surname>Durner</surname><given-names>J</given-names></name><name><surname>Brünnler</surname><given-names>G</given-names></name><name><surname>Götte</surname><given-names>H</given-names></name><name><surname>Deppner</surname><given-names>C</given-names></name><name><surname>Bender-Götze</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>HLA association is different in children and adults with severe acquired aplastic anemia</article-title>. <source>Pediatr Blood Cancer</source> (<year>2007</year>) <volume>48</volume>:<fpage>186</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.20785</pub-id><pub-id pub-id-type="pmid">16496287</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>N</given-names></name><name><surname>Butler</surname><given-names>MO</given-names></name><name><surname>Von Bergwelt-Baildon</surname><given-names>MS</given-names></name><name><surname>Maecker</surname><given-names>B</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>O’Connor</surname><given-names>KC</given-names></name><etal></etal></person-group><article-title>Autoantibodies frequently detected in patients with aplastic anemia</article-title>. <source>Blood</source> (<year>2003</year>) <volume>102</volume>:<fpage>4567</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-11-3409</pub-id><pub-id pub-id-type="pmid">12947009</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamatsu</surname><given-names>H</given-names></name><name><surname>Espinoza</surname><given-names>JL</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>Z</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Nakao</surname><given-names>S</given-names></name></person-group>. <article-title>Anti-moesin antibodies in the serum of patients with aplastic anemia stimulate peripheral blood mononuclear cells to secrete TNF-alpha and IFN-gamma</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>703</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.182.1.703</pub-id><pub-id pub-id-type="pmid">19109204</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>NS</given-names></name></person-group>. <article-title>Current concepts in the pathophysiology and treatment of aplastic anemia</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2013</year>) <volume>2013</volume>:<fpage>76</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2013.1.76</pub-id><pub-id pub-id-type="pmid">24319166</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Führer</surname><given-names>M</given-names></name><name><surname>Rampf</surname><given-names>U</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Faldum</surname><given-names>A</given-names></name><name><surname>Niemeyer</surname><given-names>C</given-names></name><name><surname>Janka-Schaub</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival</article-title>. <source>Blood</source> (<year>2005</year>) <volume>106</volume>:<fpage>2102</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-03-0874</pub-id><pub-id pub-id-type="pmid">15933058</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>D</given-names></name><name><surname>Lier</surname><given-names>A</given-names></name><name><surname>Geiselhart</surname><given-names>A</given-names></name><name><surname>Thalheimer</surname><given-names>FB</given-names></name><name><surname>Huntscha</surname><given-names>S</given-names></name><name><surname>Sobotta</surname><given-names>MC</given-names></name><etal></etal></person-group><article-title>Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells</article-title>. <source>Nature</source> (<year>2015</year>) <volume>520</volume>(<issue>7548</issue>):<fpage>549</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1038/nature14131</pub-id><pub-id pub-id-type="pmid">25707806</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietras</surname><given-names>EM</given-names></name><name><surname>Lakshminarasimhan</surname><given-names>R</given-names></name><name><surname>Techner</surname><given-names>JM</given-names></name><name><surname>Fong</surname><given-names>S</given-names></name><name><surname>Flach</surname><given-names>J</given-names></name><name><surname>Binnewies</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons</article-title>. <source>J Exp Med</source> (<year>2014</year>) <volume>211</volume>:<fpage>245</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20131043</pub-id><pub-id pub-id-type="pmid">24493802</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulycheva</surname><given-names>E</given-names></name><name><surname>Rauner</surname><given-names>M</given-names></name><name><surname>Medyouf</surname><given-names>H</given-names></name><name><surname>Theurl</surname><given-names>I</given-names></name><name><surname>Bornhäuser</surname><given-names>M</given-names></name><name><surname>Hofbauer</surname><given-names>LC</given-names></name><etal></etal></person-group><article-title>Myelodysplasia is in the niche: novel concepts and emerging therapies</article-title>. <source>Leukemia</source> (<year>2015</year>) <volume>29</volume>:<fpage>259</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1038/leu.2014.325</pub-id><pub-id pub-id-type="pmid">25394715</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Xing</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Interleukin-27 enhances the production of tumour necrosis factor-alpha and interferon-gamma by bone marrow T lymphocytes in aplastic anaemia</article-title>. <source>Br J Haematol</source> (<year>2011</year>) <volume>153</volume>:<fpage>764</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2141.2010.08431.x</pub-id><pub-id pub-id-type="pmid">21506940</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloand</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Maciejewski</surname><given-names>JP</given-names></name><name><surname>Tisdale</surname><given-names>J</given-names></name><name><surname>Follmann</surname><given-names>D</given-names></name><name><surname>Young</surname><given-names>NS</given-names></name></person-group>. <article-title>Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia</article-title>. <source>Blood</source> (<year>2002</year>) <volume>100</volume>:<fpage>1185</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-01-0035</pub-id><pub-id pub-id-type="pmid">12149196</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>CY</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>HQ</given-names></name><name><surname>Li</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Fas/FasL in the immune pathogenesis of severe aplastic anemia</article-title>. <source>Genet Mol Res</source> (<year>2014</year>) <volume>13</volume>:<fpage>4083</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4238/2014.May.30.3</pub-id><pub-id pub-id-type="pmid">24938700</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakumaran</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>PJ</given-names></name><name><surname>Pawelczyk</surname><given-names>E</given-names></name><name><surname>Yoshizawa</surname><given-names>S</given-names></name><name><surname>Sworder</surname><given-names>BJ</given-names></name><name><surname>Cherman</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders</article-title>. <source>Blood</source> (<year>2015</year>) <volume>125</volume>:<fpage>793</fpage>–<lpage>802</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2014-06-566810</pub-id><pub-id pub-id-type="pmid">25499762</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecourt</surname><given-names>S</given-names></name><name><surname>Vanneaux</surname><given-names>V</given-names></name><name><surname>Leblanc</surname><given-names>T</given-names></name><name><surname>Leroux</surname><given-names>G</given-names></name><name><surname>Ternaux</surname><given-names>B</given-names></name><name><surname>Benbunan</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients</article-title>. <source>Stem Cells Dev</source> (<year>2010</year>) <volume>19</volume>:<fpage>203</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1089/scd.2009.0062</pub-id><pub-id pub-id-type="pmid">19572808</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santamaría</surname><given-names>C</given-names></name><name><surname>Muntión</surname><given-names>S</given-names></name><name><surname>Rosón</surname><given-names>B</given-names></name><name><surname>Blanco</surname><given-names>B</given-names></name><name><surname>López-Villar</surname><given-names>O</given-names></name><name><surname>Carrancio</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients</article-title>. <source>Haematologica</source> (<year>2012</year>) <volume>97</volume>:<fpage>1218</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.3324/haematol.2011.054437</pub-id><pub-id pub-id-type="pmid">22371183</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raaijmakers</surname><given-names>MH</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Schoonmaker</surname><given-names>JA</given-names></name><etal></etal></person-group><article-title>Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia</article-title>. <source>Nature</source> (<year>2010</year>) <volume>464</volume>:<fpage>852</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature08851</pub-id><pub-id pub-id-type="pmid">20305640</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medyouf</surname><given-names>H</given-names></name><name><surname>Mossner</surname><given-names>M</given-names></name><name><surname>Jann</surname><given-names>JC</given-names></name><name><surname>Nolte</surname><given-names>F</given-names></name><name><surname>Raffel</surname><given-names>S</given-names></name><name><surname>Herrmann</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit</article-title>. <source>Cell Stem Cell</source> (<year>2014</year>) <volume>14</volume>:<fpage>824</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1016/j.stem.2014.02.014</pub-id><pub-id pub-id-type="pmid">24704494</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>Ruiz-Perez</surname><given-names>VL</given-names></name><name><surname>Woods</surname><given-names>CG</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name><name><surname>Goodship</surname><given-names>JA</given-names></name></person-group>. <article-title>A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome</article-title>. <source>Nat Genet</source> (<year>2003</year>) <volume>33</volume>:<fpage>497</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="doi">10.1038/ng1129</pub-id><pub-id pub-id-type="pmid">12640452</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seneca</surname><given-names>S</given-names></name><name><surname>De Meirleir</surname><given-names>L</given-names></name><name><surname>De Schepper</surname><given-names>J</given-names></name><name><surname>Balduck</surname><given-names>N</given-names></name><name><surname>Jochmans</surname><given-names>K</given-names></name><name><surname>Liebaers</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>Pearson marrow pancreas syndrome: a molecular study and clinical management</article-title>. <source>Clin Genet</source> (<year>1997</year>) <volume>51</volume>:<fpage>338</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1111/j.1399-0004.1997.tb02484.x</pub-id><pub-id pub-id-type="pmid">9212183</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimamura</surname><given-names>A</given-names></name></person-group><article-title>Clinical approach to marrow failure</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2009</year>) <volume>2009</volume>(<issue>1</issue>):<fpage>329</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2009.1.329</pub-id><pub-id pub-id-type="pmid">20008218</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corey</surname><given-names>SJ</given-names></name><name><surname>Minden</surname><given-names>MD</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Kantarjian</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Schimmer</surname><given-names>AD</given-names></name></person-group>. <article-title>Myelodysplastic syndromes: the complexity of stem-cell diseases</article-title>. <source>Nat Rev Cancer</source> (<year>2007</year>) <volume>7</volume>:<fpage>118</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1038/nrc2047</pub-id><pub-id pub-id-type="pmid">17251918</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>JE</given-names></name><name><surname>Mufti</surname><given-names>GJ</given-names></name><name><surname>Rasool</surname><given-names>F</given-names></name><name><surname>Mijovic</surname><given-names>A</given-names></name><name><surname>Devereux</surname><given-names>S</given-names></name><name><surname>Pagliuca</surname><given-names>A</given-names></name></person-group>. <article-title>The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS</article-title>. <source>Blood</source> (<year>2000</year>) <volume>96</volume>:<fpage>3932</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">11090080</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jaffe</surname><given-names>ES</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name><name><surname>Vardiman</surname><given-names>JW.</given-names></name></person-group><source>World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues</source>. <publisher-loc>Lyon</publisher-loc>: <publisher-name>IARC Press</publisher-name> (<year>2008</year>). Ref Type: Generic.</mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasle</surname><given-names>H</given-names></name><name><surname>Niemeyer</surname><given-names>CM</given-names></name><name><surname>Chessells</surname><given-names>JM</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Bennett</surname><given-names>JM</given-names></name><name><surname>Kerndrup</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases</article-title>. <source>Leukemia</source> (<year>2003</year>) <volume>17</volume>:<fpage>277</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1038/sj.leu.2402765</pub-id><pub-id pub-id-type="pmid">12592323</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemeyer</surname><given-names>CM</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name></person-group>. <article-title>Classification of childhood aplastic anemia and myelodysplastic syndrome</article-title>. <source>Hematology Am Soc Hematol Educ Program</source> (<year>2011</year>) <volume>2011</volume>:<fpage>84</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/asheducation-2011.1.84</pub-id><pub-id pub-id-type="pmid">22160017</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luna-Fineman</surname><given-names>S</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name><name><surname>Atwater</surname><given-names>SK</given-names></name><name><surname>Davis</surname><given-names>J</given-names></name><name><surname>Masterson</surname><given-names>M</given-names></name><name><surname>Ortega</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients</article-title>. <source>Blood</source> (<year>1999</year>) <volume>93</volume>:<fpage>459</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">9885207</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passmore</surname><given-names>SJ</given-names></name><name><surname>Chessells</surname><given-names>JM</given-names></name><name><surname>Kempski</surname><given-names>H</given-names></name><name><surname>Hann</surname><given-names>IM</given-names></name><name><surname>Brownbill</surname><given-names>PA</given-names></name><name><surname>Stiller</surname><given-names>CA</given-names></name></person-group>. <article-title>Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival</article-title>. <source>Br J Haematol</source> (<year>2003</year>) <volume>121</volume>:<fpage>758</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2141.2003.04361.x</pub-id><pub-id pub-id-type="pmid">12780790</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Göhring</surname><given-names>G</given-names></name><name><surname>Michalova</surname><given-names>K</given-names></name><name><surname>Beverloo</surname><given-names>HB</given-names></name><name><surname>Betts</surname><given-names>D</given-names></name><name><surname>Harbott</surname><given-names>J</given-names></name><name><surname>Haas</surname><given-names>OA</given-names></name><etal></etal></person-group><article-title>Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome</article-title>. <source>Blood</source> (<year>2010</year>) <volume>116</volume>:<fpage>3766</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2010-04-280313</pub-id><pub-id pub-id-type="pmid">20802024</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardos</surname><given-names>G</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Passmore</surname><given-names>SJ</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Hasle</surname><given-names>H</given-names></name><name><surname>Schultz</surname><given-names>KR</given-names></name><etal></etal></person-group><article-title>Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7</article-title>. <source>Blood</source> (<year>2003</year>) <volume>102</volume>:<fpage>1997</fpage>–<lpage>2003</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-11-3444</pub-id><pub-id pub-id-type="pmid">12763938</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantadakis</surname><given-names>E</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name><name><surname>Singer</surname><given-names>DA</given-names></name><name><surname>Finklestein</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>KW</given-names></name><name><surname>Hilden</surname><given-names>JM</given-names></name><etal></etal></person-group><article-title>Transient monosomy 7: a case series in children and review of the literature</article-title>. <source>Cancer</source> (<year>1999</year>) <volume>85</volume>:<fpage>2655</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19990615)85:12<2655::AID-CNCR23>3.0.CO;2-W</pub-id><pub-id pub-id-type="pmid">10375115</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>AH</given-names></name><name><surname>Godley</surname><given-names>LA</given-names></name><name><surname>Churpek</surname><given-names>JE</given-names></name></person-group>. <article-title>Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations</article-title>. <source>Ann N Y Acad Sci</source> (<year>2014</year>) <volume>1310</volume>:<fpage>111</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/nyas.12346</pub-id><pub-id pub-id-type="pmid">24467820</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname><given-names>M</given-names></name><name><surname>Dickinson</surname><given-names>R</given-names></name><name><surname>Bigley</surname><given-names>V</given-names></name></person-group>. <article-title>Haematopoietic and immune defects associated with GATA2 mutation</article-title>. <source>Br J Haematol</source> (<year>2015</year>) <volume>169</volume>:<fpage>173</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1111/bjh.13317</pub-id><pub-id pub-id-type="pmid">25707267</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gluckman</surname><given-names>E</given-names></name><name><surname>Marmont</surname><given-names>A</given-names></name><name><surname>Speck</surname><given-names>B</given-names></name><name><surname>Gordon-Smith</surname><given-names>EC</given-names></name></person-group><article-title>Immunosuppressive treatment of aplastic anemia as an alternative treatment for bone marrow transplantation</article-title>. <source>Semin Hematol</source> (<year>1984</year>) <volume>21</volume>:<fpage>11</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">6367052</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speck</surname><given-names>B</given-names></name><name><surname>Cornu</surname><given-names>P</given-names></name><name><surname>Jeannet</surname><given-names>M</given-names></name><name><surname>Nissen</surname><given-names>C</given-names></name><name><surname>Burri</surname><given-names>HP</given-names></name><name><surname>Groff</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia</article-title>. <source>Exp Hematol</source> (<year>1976</year>) <volume>4</volume>:<fpage>131</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">773651</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>XY</given-names></name><name><surname>Ma</surname><given-names>SH</given-names></name><name><surname>Zhang</surname><given-names>FK</given-names></name><name><surname>Zhen</surname><given-names>JH</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia</article-title>. <source>J Intern Med</source> (<year>2014</year>) <volume>276</volume>:<fpage>512</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1111/joim.12218</pub-id><pub-id pub-id-type="pmid">24528288</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochenderfer</surname><given-names>JN</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Wieder</surname><given-names>ED</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Molldrem</surname><given-names>JJ</given-names></name></person-group>. <article-title>Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression</article-title>. <source>Blood</source> (<year>2002</year>) <volume>100</volume>:<fpage>3639</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-01-0155</pub-id><pub-id pub-id-type="pmid">12393644</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wlodarski</surname><given-names>MW</given-names></name><name><surname>Gondek</surname><given-names>LP</given-names></name><name><surname>Nearman</surname><given-names>ZP</given-names></name><name><surname>Plasilova</surname><given-names>M</given-names></name><name><surname>Kalaycio</surname><given-names>M</given-names></name><name><surname>Hsi</surname><given-names>ED</given-names></name><etal></etal></person-group><article-title>Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome</article-title>. <source>Blood</source> (<year>2006</year>) <volume>108</volume>:<fpage>2632</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-09-3902</pub-id><pub-id pub-id-type="pmid">16614248</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Maciejewski</surname><given-names>JP</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Young</surname><given-names>NS</given-names></name></person-group>. <article-title>Limited heterogeneity of T cell receptor BV usage in aplastic anemia</article-title>. <source>J Clin Invest</source> (<year>2001</year>) <volume>108</volume>:<fpage>765</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1172/JCI200112687</pub-id><pub-id pub-id-type="pmid">11544283</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risitano</surname><given-names>AM</given-names></name><name><surname>Maciejewski</surname><given-names>JP</given-names></name><name><surname>Green</surname><given-names>S</given-names></name><name><surname>Plasilova</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Young</surname><given-names>NS</given-names></name></person-group>. <article-title>In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing</article-title>. <source>Lancet</source> (<year>2004</year>) <volume>364</volume>:<fpage>355</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(04)16724-X</pub-id><pub-id pub-id-type="pmid">15276395</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal></etal></person-group><article-title>CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia</article-title>. <source>Mol Med Rep.</source> (<year>2014</year>) <volume>10</volume>:<fpage>1252</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.3892/mmr.2014.2344</pub-id><pub-id pub-id-type="pmid">24969051</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babushok</surname><given-names>DV</given-names></name><name><surname>Perdigones</surname><given-names>N</given-names></name><name><surname>Perin</surname><given-names>JC</given-names></name><name><surname>Olson</surname><given-names>TS</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Roth</surname><given-names>JJ</given-names></name><etal></etal></person-group><article-title>Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia</article-title>. <source>Cancer Genet</source> (<year>2015</year>) <volume>208</volume>(<issue>4</issue>):<fpage>115</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1016/j.cancergen.2015.01.007</pub-id><pub-id pub-id-type="pmid">25800665</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasle</surname><given-names>H</given-names></name><name><surname>Heim</surname><given-names>S</given-names></name><name><surname>Schroeder</surname><given-names>H</given-names></name><name><surname>Schmiegelow</surname><given-names>K</given-names></name><name><surname>Ostergaard</surname><given-names>E</given-names></name><name><surname>Kerndrup</surname><given-names>G</given-names></name></person-group><article-title>Transient pancytopenia preceding acute lymphoblastic leukemia (pre-ALL)</article-title>. <source>Leukemia</source> (<year>1995</year>) <volume>9</volume>:<fpage>605</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">7723392</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villarreal-Martinez</surname><given-names>L</given-names></name><name><surname>Jaime-Perez</surname><given-names>JC</given-names></name><name><surname>Rodriguez-Martinez</surname><given-names>M</given-names></name><name><surname>Gonzalez-Llano</surname><given-names>O</given-names></name><name><surname>Gomez-Almaguer</surname><given-names>D</given-names></name></person-group>. <article-title>Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases</article-title>. <source>Rev Bras Hematol Hemoter.</source> (<year>2012</year>) <volume>34</volume>:<fpage>165</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.5581/1516-8484.20120037</pub-id><pub-id pub-id-type="pmid">23049407</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Führer</surname><given-names>M</given-names></name><name><surname>Behrendt</surname><given-names>S</given-names></name><name><surname>Campr</surname><given-names>V</given-names></name><name><surname>Csomor</surname><given-names>J</given-names></name><name><surname>Furlan</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria</article-title>. <source>Histopathology</source> (<year>2012</year>) <volume>61</volume>:<fpage>10</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2559.2011.04156.x</pub-id><pub-id pub-id-type="pmid">22458667</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Calado</surname><given-names>RT</given-names></name><name><surname>Ly</surname><given-names>H</given-names></name><name><surname>Kajigaya</surname><given-names>S</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><etal></etal></person-group><article-title>Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia</article-title>. <source>N Engl J Med</source> (<year>2005</year>) <volume>352</volume>:<fpage>1413</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa042980</pub-id><pub-id pub-id-type="pmid">15814878</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fibbe</surname><given-names>WE</given-names></name></person-group><article-title>Telomerase mutations in aplastic anemia</article-title>. <source>N Engl J Med</source> (<year>2005</year>) <volume>352</volume>:<fpage>1481</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMe058015</pub-id><pub-id pub-id-type="pmid">15814885</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumitriu</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Townsley</surname><given-names>DM</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Yoshizato</surname><given-names>T</given-names></name><name><surname>Calado</surname><given-names>RT</given-names></name><etal></etal></person-group><article-title>Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia</article-title>. <source>Blood</source> (<year>2015</year>) <volume>125</volume>:<fpage>706</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2014-10-607572</pub-id><pub-id pub-id-type="pmid">25406353</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welte</surname><given-names>K</given-names></name><name><surname>Zeidler</surname><given-names>C</given-names></name><name><surname>Reiter</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>W</given-names></name><name><surname>Odenwald</surname><given-names>E</given-names></name><name><surname>Souza</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia</article-title>. <source>Blood</source> (<year>1990</year>) <volume>75</volume>:<fpage>1056</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">1689595</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connelly</surname><given-names>JA</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Levine</surname><given-names>JE</given-names></name></person-group>. <article-title>Hematopoietic stem cell transplantation for severe congenital neutropenia</article-title>. <source>Curr Opin Hematol</source> (<year>2012</year>) <volume>19</volume>:<fpage>44</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1097/MOH.0b013e32834da96e</pub-id><pub-id pub-id-type="pmid">22080845</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmer</surname><given-names>J</given-names></name><name><surname>Hentges</surname><given-names>F</given-names></name><name><surname>Andres</surname><given-names>E</given-names></name></person-group><article-title>Eltrombopag in thrombocytopenia</article-title>. <source>N Engl J Med</source> (<year>2008</year>) <volume>358</volume>:<fpage>1072</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMc073571</pub-id><pub-id pub-id-type="pmid">18326076</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olnes</surname><given-names>MJ</given-names></name><name><surname>Scheinberg</surname><given-names>P</given-names></name><name><surname>Calvo</surname><given-names>KR</given-names></name><name><surname>Desmond</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Dumitriu</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>Eltrombopag and improved hematopoiesis in refractory aplastic anemia</article-title>. <source>N Engl J Med</source> (<year>2012</year>) <volume>367</volume>:<fpage>11</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1200931</pub-id><pub-id pub-id-type="pmid">22762314</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>A</given-names></name><name><surname>Rafiq</surname><given-names>S</given-names></name><name><surname>Kirwan</surname><given-names>M</given-names></name><name><surname>Walne</surname><given-names>A</given-names></name><name><surname>Cavenagh</surname><given-names>J</given-names></name><name><surname>Vulliamy</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Haematological recovery in dyskeratosis congenita patients treated with danazol</article-title>. <source>Br J Haematol</source> (<year>2013</year>) <volume>162</volume>:<fpage>854</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1111/bjh.12432</pub-id><pub-id pub-id-type="pmid">23782100</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheckenbach</surname><given-names>K</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Filger-Brillinger</surname><given-names>J</given-names></name><name><surname>Sandmann</surname><given-names>M</given-names></name><name><surname>Strimling</surname><given-names>B</given-names></name><name><surname>Scheurlen</surname><given-names>W</given-names></name><etal></etal></person-group><article-title>Treatment of the bone marrow failure in Fanconi anemia patients with danazol</article-title>. <source>Blood Cells Mol Dis</source> (<year>2012</year>) <volume>48</volume>:<fpage>128</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/j.bcmd.2011.11.006</pub-id><pub-id pub-id-type="pmid">22178060</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaime-Pérez</surname><given-names>JC</given-names></name><name><surname>Colunga-Pedraza</surname><given-names>PR</given-names></name><name><surname>Gómez-Ramírez</surname><given-names>CD</given-names></name><name><surname>Gutiérrez-Aguirre</surname><given-names>CH</given-names></name><name><surname>Cantú-Rodríguez</surname><given-names>OG</given-names></name><name><surname>Tarín-Arzaga</surname><given-names>LC</given-names></name><etal></etal></person-group><article-title>Danazol as first-line therapy for aplastic anemia</article-title>. <source>Ann Hematol</source> (<year>2011</year>) <volume>90</volume>:<fpage>523</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/s00277-011-1163-x</pub-id><pub-id pub-id-type="pmid">21279356</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>SR</given-names></name><name><surname>Kim</surname><given-names>MO</given-names></name><name><surname>Korbee</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>KA</given-names></name><name><surname>Ris</surname><given-names>MD</given-names></name><name><surname>Eyal</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>Oxandrolone for the treatment of bone marrow failure in Fanconi anemia</article-title>. <source>Pediatr Blood Cancer</source> (<year>2014</year>) <volume>61</volume>:<fpage>11</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.24617</pub-id><pub-id pub-id-type="pmid">24019220</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarasinghe</surname><given-names>S</given-names></name><name><surname>Marsh</surname><given-names>J</given-names></name><name><surname>Dufour</surname><given-names>C</given-names></name></person-group><article-title>Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?</article-title><source>Haematologica</source> (<year>2014</year>) <volume>99</volume>:<fpage>597</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.3324/haematol.2014.105569</pub-id><pub-id pub-id-type="pmid">24688105</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheinberg</surname><given-names>P</given-names></name><name><surname>Nunez</surname><given-names>O</given-names></name><name><surname>Weinstein</surname><given-names>B</given-names></name><name><surname>Scheinberg</surname><given-names>P</given-names></name><name><surname>Biancotto</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>CO</given-names></name><etal></etal></person-group><article-title>Horse versus rabbit antithymocyte globulin in acquired aplastic anemia</article-title>. <source>N Engl J Med</source> (<year>2011</year>) <volume>365</volume>:<fpage>430</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1103975</pub-id><pub-id pub-id-type="pmid">21812672</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>JC</given-names></name><name><surname>Bacigalupo</surname><given-names>A</given-names></name><name><surname>Schrezenmeier</surname><given-names>H</given-names></name><name><surname>Tichelli</surname><given-names>A</given-names></name><name><surname>Risitano</surname><given-names>AM</given-names></name><name><surname>Passweg</surname><given-names>JR</given-names></name><etal></etal></person-group><article-title>Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>:<fpage>5391</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-02-407684</pub-id><pub-id pub-id-type="pmid">22544699</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimi</surname><given-names>A</given-names></name><name><surname>Niemeyer</surname><given-names>CM</given-names></name><name><surname>Fuhrer</surname><given-names>MM</given-names></name><name><surname>Strahm</surname><given-names>B</given-names></name></person-group><article-title>Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children</article-title>. <source>Blood</source> (<year>2013</year>) <volume>121</volume>:<fpage>860</fpage>–<lpage>1</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-10-461509</pub-id><pub-id pub-id-type="pmid">23372153</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloand</surname><given-names>EM</given-names></name><name><surname>Wu</surname><given-names>CO</given-names></name><name><surname>Greenberg</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>N</given-names></name><name><surname>Barrett</surname><given-names>J</given-names></name></person-group>. <article-title>Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy</article-title>. <source>J Clin Oncol</source> (<year>2008</year>) <volume>26</volume>:<fpage>2505</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1200/JCO.2007.11.9214</pub-id><pub-id pub-id-type="pmid">18413642</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimi</surname><given-names>A</given-names></name><name><surname>van den Heuvel-Eibrink</surname><given-names>MM</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Simonitsch-Klupp</surname><given-names>I</given-names></name><name><surname>de Paepe</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood</article-title>. <source>Haematologica</source> (<year>2014</year>) <volume>99</volume>:<fpage>656</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.3324/haematol.2013.095786</pub-id><pub-id pub-id-type="pmid">24162791</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>D</given-names></name><name><surname>Manabe</surname><given-names>A</given-names></name><name><surname>Yagasaki</surname><given-names>H</given-names></name><name><surname>Ohtsuka</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99)</article-title>. <source>Pediatr Blood Cancer</source> (<year>2009</year>) <volume>53</volume>:<fpage>1011</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.22121</pub-id><pub-id pub-id-type="pmid">19499580</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Porta</surname><given-names>F</given-names></name><name><surname>Zecca</surname><given-names>M</given-names></name><name><surname>Pedrazzoli</surname><given-names>P</given-names></name><name><surname>Maccario</surname><given-names>R</given-names></name><name><surname>Giani</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors</article-title>. <source>Am J Hematol</source> (<year>1993</year>) <volume>42</volume>:<fpage>328</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1002/ajh.2830420315</pub-id><pub-id pub-id-type="pmid">8438907</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarasinghe</surname><given-names>S</given-names></name><name><surname>Steward</surname><given-names>C</given-names></name><name><surname>Hiwarkar</surname><given-names>P</given-names></name><name><surname>Saif</surname><given-names>MA</given-names></name><name><surname>Hough</surname><given-names>R</given-names></name><name><surname>Webb</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience</article-title>. <source>Br J Haematol</source> (<year>2012</year>) <volume>157</volume>:<fpage>339</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2141.2012.09066.x</pub-id><pub-id pub-id-type="pmid">22372373</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maury</surname><given-names>S</given-names></name><name><surname>Balère-Appert</surname><given-names>ML</given-names></name><name><surname>Pollichieni</surname><given-names>S</given-names></name><name><surname>Oneto</surname><given-names>R</given-names></name><name><surname>Yakoub-Agha</surname><given-names>I</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia</article-title>. <source>Am J Hematol</source> (<year>2013</year>) <volume>88</volume>:<fpage>868</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1002/ajh.23522</pub-id><pub-id pub-id-type="pmid">23804195</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrer</surname><given-names>M</given-names></name></person-group>. <article-title>Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia</article-title>. <source>Bone Marrow Transplant</source> (<year>2008</year>) <volume>42</volume>(<issue>Suppl 2</issue>):<fpage>S97</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1038/bmt.2008.293</pub-id><pub-id pub-id-type="pmid">18978755</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strahm</surname><given-names>B</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Bader</surname><given-names>P</given-names></name><name><surname>Ehlert</surname><given-names>K</given-names></name><name><surname>Kremens</surname><given-names>B</given-names></name><name><surname>Zintl</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood</article-title>. <source>Bone Marrow Transplant</source> (<year>2007</year>) <volume>40</volume>:<fpage>329</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1038/sj.bmt.1705730</pub-id><pub-id pub-id-type="pmid">17589538</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strahm</surname><given-names>B</given-names></name><name><surname>Nöllke</surname><given-names>P</given-names></name><name><surname>Zecca</surname><given-names>M</given-names></name><name><surname>Korthof</surname><given-names>ET</given-names></name><name><surname>Bierings</surname><given-names>M</given-names></name><name><surname>Furlan</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study</article-title>. <source>Leukemia</source> (<year>2011</year>) <volume>25</volume>:<fpage>455</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1038/leu.2010.297</pub-id><pub-id pub-id-type="pmid">21212791</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMillan</surname><given-names>ML</given-names></name><name><surname>Wagner</surname><given-names>JE</given-names></name></person-group>. <article-title>Hematopoietic cell transplantation for congenital bone marrow failure</article-title>. <source>Curr Opin Oncol</source> (<year>2005</year>) <volume>17</volume>:<fpage>106</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1097/01.cco.0000152977.55175.5b</pub-id><pub-id pub-id-type="pmid">15725913</pub-id></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000516 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000516 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:4500095
|texte= Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:26217651" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |